###begin article-title 0
###xml 4 8 4 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GNAS</italic>
The GNAS Locus: Quintessential Complex Gene Encoding Gsalpha, XLalphas, and other Imprinted Transcripts
###end article-title 0
###begin p 1
###xml 104 147 104 147 <uri xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:type="simple" xlink:href="http://creativecommons.org/licenses/by/2.5/">http://creativecommons.org/licenses/by/2.5/</uri>
This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.5/) which permits unrestrictive use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin p 2
###xml 265 269 265 269 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GNAS</italic>
###xml 559 563 547 551 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GNAS</italic>
###xml 946 950 926 930 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GNAS</italic>
###xml 1020 1024 1000 1004 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GNAS</italic>
###xml 1188 1192 1160 1164 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GNAS</italic>
###xml 1271 1278 1243 1250 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vivo</italic>
###xml 1363 1367 1335 1339 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GNAS</italic>
###xml 1504 1508 1476 1480 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GNAS</italic>
###xml 1775 1779 1747 1751 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GNAS</italic>
###xml 47 52 <span type="species:ncbi:9606">human</span>
###xml 591 596 <span type="species:ncbi:9606">human</span>
The currently estimated number of genes in the human genome is much smaller than previously predicted. As an explanation for this disparity, most individual genes have multiple transcriptional units that represent a variety of biologically important gene products. GNAS exemplifies a gene of such complexity. One of its products is the alpha-subunit of the stimulatory heterotrimeric G protein (Gsalpha), a ubiquitous signaling protein essential for numerous different cellular responses. Loss-of-function and gain-of-function mutations within Gsalpha-coding GNAS exons are found in various human disorders, including Albright's hereditary osteodystrophy, pseudohypoparathyroidism, fibrous dysplasia of bone, and some tumors of different origin. While Gsalpha expression in most tissues is biallelic, paternal Gsalpha expression is silenced in a small number of tissues, playing an important role in the development of phenotypes associated with GNAS mutations. Additional products derived exclusively from the paternal GNAS allele include XLalphas, a protein partially identical to Gsalpha, and two non-coding RNA molecules, the A/B transcript and the antisense transcript. The maternal GNAS allele leads to NESP55, a chromogranin-like neuroendocrine secretory protein. In vivo animal models have demonstrated the importance of each of the exclusively imprinted GNAS products in normal mammalian physiology. However, although one or more of these products are also disrupted by most naturally occurring GNAS mutations, their roles in disease pathogenesis remain unknown. To further our understanding of the significance of this gene in physiology and pathophysiology, it will be important to elucidate the cellular roles and the mechanisms regulating the expression of each GNAS product.
###end p 2
###begin title 3
INTRODUCTION
###end title 3
###begin p 4
###xml 133 134 133 134 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R1">1</xref>
###xml 135 137 135 137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R2"> 2</xref>
###xml 491 492 491 492 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R3">3</xref>
###xml 493 495 493 495 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R4"> 4</xref>
###xml 786 787 786 787 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R5">5</xref>
###xml 876 877 876 877 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R6">6</xref>
###xml 878 879 878 879 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R9">9</xref>
###xml 1364 1368 1364 1368 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GNAS</italic>
###xml 23 28 <span type="species:ncbi:9606">human</span>
###xml 91 96 <span type="species:ncbi:9606">Human</span>
###xml 403 408 <span type="species:ncbi:9606">human</span>
###xml 558 563 <span type="species:ncbi:9606">human</span>
###xml 1246 1251 <span type="species:ncbi:9606">human</span>
The first draft of the human genome DNA sequence was reported in 2001 independently by the Human Genome Project and Celera Genomics [1, 2]. Since this important landmark in medical research, the entire research community has had access to a wealth of information that would otherwise have taken many years to gather, resulting in a tremendous acceleration of virtually all research studies that involve human biology or disease. With updates of the project, the sequence is nearly complete [3, 4]. It is interesting, however, that the number of genes in the human genome appears to be much smaller than initially estimated. Although the exact number of genes in the genome still remains unknown, more recent estimate for the number of protein-coding genes is between 20,000 and 25,000 [5], which markedly differs from the previously predicted number of approximately 100,000 [6-9]. The currently estimated gene number, of course, appears quite small, considering the complexity of our species. However, the difference between the older and most recent predictions of the gene number can be accounted for by the presence of multiple transcriptional units associated with many individual genes. In fact, the total number of proteins encoded by the human genome may be similar to, if not higher than, the past estimates of the gene number. This review focuses on the GNAS locus, which exemplifies a complex gene with multiple gene products derived through alternative promoter use and alternative pre-mRNA splicing.
###end p 4
###begin title 5
###xml 12 16 12 16 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GNAS</italic>
THE COMPLEX GNAS LOCUS AND Gsalpha
###end title 5
###begin p 6
###xml 10 14 10 14 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GNAS</italic>
###xml 99 101 99 101 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R10">10</xref>
###xml 102 104 102 104 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R12">12</xref>
###xml 167 169 167 169 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R13">13</xref>
###xml 170 173 170 173 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R14"> 14</xref>
###xml 176 180 176 180 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GNAS</italic>
###xml 438 439 438 439 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">1</xref>
###xml 438 439 438 439 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="fig" rid="F1">1</xref></bold>
###xml 466 470 466 470 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GNAS</italic>
###xml 564 568 564 568 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GNAS</italic>
###xml 829 833 821 825 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GNAS</italic>
###xml 979 983 963 967 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GNAS</italic>
###xml 4 9 <span type="species:ncbi:9606">human</span>
###xml 117 122 <span type="species:ncbi:10090">mouse</span>
###xml 184 190 <span type="species:ncbi:9606">humans</span>
###xml 195 199 <span type="species:ncbi:10090">mice</span>
The human GNAS locus maps to the telomeric end of the long arm of chromosome 20 (20q13.2-20q13.3) [10-12], while its mouse ortholog is located in distal chromosome 2 [13, 14]. GNAS in humans and mice appear structurally and functionally similar to one and other. This locus has multiple promoters and differentially methylated regions (DMR) and gives rise to non-coding RNA molecules and transcripts that encode functional proteins (Fig. 1). Furthermore, nearly all GNAS products show parent-of-origin specific expression. Among the multiple products derived from GNAS, the best characterized protein is the alpha-subunit of the heterotrimeric stimulatory G protein (Gsalpha), which has at least five variants that result from alternative pre-mRNA splicing. Derived from distinct promoters are at least four different additional GNAS products, including the neuroendocrine secretory protein 55 (NESP55), the extra-large variant of Gsalpha (XLalphas), the A/B transcript, and the GNAS antisense transcript. Most of these additional transcripts also undergo alternative splicing and, thus, have different variants.
###end p 6
###begin p 7
###xml 579 581 541 543 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R15">15</xref>
###xml 608 610 570 572 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R16">16</xref>
###xml 611 614 573 576 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R17"> 17</xref>
###xml 1485 1488 1431 1434 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">201</sup>
###xml 1496 1499 1442 1445 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">227</sup>
###xml 1584 1587 1530 1533 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">201</sup>
###xml 1753 1755 1695 1697 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R18">18</xref>
###xml 1756 1758 1698 1700 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R21">21</xref>
###xml 1948 1950 1882 1884 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R22">22</xref>
###xml 1951 1954 1885 1888 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R23"> 23</xref>
Gsalpha is a ubiquitous protein whose activity is essential for the cellular actions of many neurotransmitters, autocrine/paracrine factors, and hormones. As in alpha-subunits of other heterotrimeric G proteins, activation of Gsalpha by an agonist-occupied cell surface receptor results in a GDP-GTP exchange on Gsalpha, causing dissociation of the latter from Gbetagamma subunits and, thereby, allowing both Gsalpha and Gbetagamma to stimulate their respective effectors. GTP-bound, free Gsalpha can directly activate several different effectors, including Src tyrosine kinase [15] and certain Ca-channels [16, 17]. However,by far the most ubiquitous and the most extensively investigated effector molecule stimulated by Gsalpha is adenylyl cyclase, an integral membrane protein that catalyzes the synthesis of the ubiquitous second messenger cyclic AMP (cAMP), thereby triggering an intracellular signaling cascade that brings about an agonist- and cell-specific response. The activation of adenylyl cyclase and other effectors by Gsalpha is tightly regulated. The intrinsic GTP hydrolase (GTPase) activity of Gsalpha reverts the GTP-bound Gsalpha to its GDP-bound state and, thereby, results in the re-assembly of the G protein heterotrimer, which can no longer mediate effector stimulation. Mutagenesis experiments often lead to alteration in activity and/or subcellular distribution, indicating that changes are non-tolerable at many of the amino acid positions. Particularly, Arg201 and Gln227 are critical, since modifications of these residues, such as ADP-ribosylation of Arg201 that can be induced by cholera toxin or mutations at either residue, lead to inhibition of the GTPase activity and, therefore, render Gsalpha constitutively active [18-21]. The receptor and GTPase dependent activation cycle of Gsalpha, structural features of Gsalpha protein, and the roles of specific Gs effectors have been reviewed in more detail elsewhere [22, 23].
###end p 7
###begin p 8
###xml 32 34 28 30 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R24">24</xref>
###xml 129 130 121 122 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">2</xref>
###xml 129 130 121 122 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="fig" rid="F2">2</xref></bold>
###xml 305 307 285 287 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R24">24</xref>
###xml 308 310 288 290 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R26">26</xref>
###xml 887 889 843 845 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R27">27</xref>
###xml 986 988 942 944 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R28">28</xref>
###xml 1065 1067 1013 1015 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R29">29</xref>
###xml 1296 1298 1229 1231 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R30">30</xref>
###xml 1524 1526 1453 1455 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R31">31</xref>
###xml 1527 1529 1456 1458 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R33">33</xref>
###xml 1937 1939 1862 1864 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R34">34</xref>
###xml 2016 2020 1937 1941 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GNAS</italic>
###xml 2216 2218 2129 2131 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R34">34</xref>
###xml 859 865 <span type="species:ncbi:9986">rabbit</span>
###xml 1890 1897 <span type="species:ncbi:9606">patient</span>
###xml 2044 2051 <span type="species:ncbi:9606">patient</span>
Gsalpha is encoded by 13 exons [24], but due to alternative pre-mRNA splicing, the Gsalpha transcript has several variants (Fig. 2). The long and the short Gsalpha variants (Gsalpha-L and Gsalpha-S, respectively) differ from each other by the inclusion or exclusion of 45 nucleotides derived from exon 3 [24-26]. Nearly all tissues express both of these Gsalpha variants, which are typically detected as 52- and 45-kDa protein bands on Western blots. In addition, each Gsalpha form either includes or excludes a CAG tri-nucleotide (encoding serine) at the start of exon 4. Some investigations have revealed small, but potentially important, differences between the activities of Gsalpha-L and Gsalpha-S. For example, Gsalpha-L has been demonstrated to have a greater ability to transmit receptor signaling than Gsalpha-S when partially purified proteins from rabbit liver were examined [27], although the opposite was suggested in an assay system using cultured pancreatic islet cells [28]. Moreover, Gsalpha-L appears to release GDP ~2-fold faster than Gsalpha-S [29], and consistent with that finding, study of fusion proteins involving the beta2-adrenergic receptor and either Gsalpha-L or Gsalpha-S has shown higher constitutive activity of the receptor when it is associated with Gsalpha-L [30]. In addition, differences in the subcellular trafficking of these two variants have been reported in response to activation by agonist, forskolin (a direct activator of adenylyl cyclase), or GTPgammaS (a stable GTP analog) [31-33]. Currently, it remains unclear whether these differences translate into biologically significant effects, such as divergence in the variety of effectors and/or the efficiency of effector activation. An important recent finding regarding the long and short Gsalpha forms is that, for the first time, an inactivating mutation in exon 3 has been identified in a patient with pseudohypoparathyroidism type-Ia [34], a disorder known to be caused by inactivating mutations in Gsalpha-coding GNAS exons (see below). The patient with the exon 3 mutation has an apparently mild form of this disorder, consistent with the disruption of only one of the two main Gsalpha variants, i.e. Gsalpha-L [34]. It is conceivable that, depending on the effector selectivity and relative expression levels of Gsalpha-L and Gsalpha-S in different tissues, this mutation impairs agonist responses in an effector- and tissue-specific manner. This possibility remains unexplored.
###end p 8
###begin p 9
###xml 88 89 80 81 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">2</xref>
###xml 88 89 80 81 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="fig" rid="F2">2</xref></bold>
###xml 291 293 275 277 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R35">35</xref>
Alternative pre-mRNA splicing leads to another Gsalpha variant, termed Gsalpha-N1 (Fig. 2). Identified first in the brain, Gsalpha-N1 is truncated in the C-terminus due to splicing of exon 3 (or exon 2 in the case of Gsalpha-S) onto a distinct exon containing an in-frame termination codon [35]. Exon N1 is located between exons 3 and 4. Gsalpha-N1 lacks most functional domains of Gsalpha, and therefore, it is probably unable to function in a way similar to the latter. Its cellular role and its biological significance remain unknown.
###end p 9
###begin title 10
TISSUE-SPECIFIC Gsalpha IMPRINTING
###end title 10
###begin p 11
###xml 184 186 180 182 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R36">36</xref>
###xml 187 189 183 185 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R39">39</xref>
###xml 393 397 381 385 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gnas</italic>
###xml 543 547 527 531 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gnas</italic>
###xml 602 604 582 584 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R40">40</xref>
###xml 985 987 953 955 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R40">40</xref>
###xml 1102 1106 1070 1074 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gnas</italic>
###xml 1230 1232 1194 1196 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R41">41</xref>
###xml 1363 1364 1323 1324 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sup>
###xml 1578 1580 1530 1532 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R42">42</xref>
###xml 209 214 <span type="species:ncbi:9606">human</span>
###xml 219 224 <span type="species:ncbi:10090">mouse</span>
###xml 360 364 <span type="species:ncbi:10090">mice</span>
###xml 510 514 <span type="species:ncbi:10090">mice</span>
###xml 808 812 <span type="species:ncbi:10090">mice</span>
###xml 846 850 <span type="species:ncbi:10090">mice</span>
###xml 1038 1042 <span type="species:ncbi:10090">mice</span>
Several studies have demonstrated that the expression of Gsalpha in most fetal and adult tissues is biallelic, consistent with the absence of differential methylation at its promoter [36-39]. However, in some human and mouse tissues, Gsalpha expression is predominantly maternal, i.e. paternal Gsalpha expression is silenced. For example, in the renal cortex, mice with paternal disruption of Gnas exon 2 exhibit Gsalpha mRNA and protein levels that are similar to those seen in wild-type littermates, whereas mice with maternal disruption of Gnas exon 2 are nearly devoid of Gsalpha mRNA and protein [40], indicating that renal cortical Gsalpha expression is derived mostly from the maternal allele. This monoallelic, parent-of-origin specific Gsalpha expression occurs in a tissue-specific manner, as both mice with the maternal disruption and mice with the paternal disruption show Gsalpha levels in the renal medulla that are about 50% of the levels seen in wild-type littermates [40]. Similar findings have been reported recently in mice heterozygous for either paternal or maternal disruption of Gnas exon 1, and these studies additionally demonstrated that Gsalpha expression is also predominantly maternal in the thyroid [41]. Consistent with these findings, the active maternal Gsalpha promoter shows a greater ratio of tri- to dimethylated histone-3 Lys4 compared to the silenced paternal promoter in the proximal tubule, whereas the amount of methylated histones is similar in maternal and paternal Gsalpha promoters in liver, a tissue in which Gsalpha is biallelic [42].
###end p 11
###begin p 12
###xml 235 237 227 229 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R43">43</xref>
###xml 238 240 230 232 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R45">45</xref>
###xml 366 368 354 356 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R44">44</xref>
###xml 369 372 357 360 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R46"> 46</xref>
###xml 373 376 361 364 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R47"> 47</xref>
###xml 518 522 502 506 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GNAS</italic>
###xml 69 74 <span type="species:ncbi:9606">human</span>
Monoallelic, maternal Gsalpha expression has also been documented in human tissues through the analysis of a single nucleotide polymorphism located in exon 5. Thus, Gsalpha is predominantly maternal in thyroid, pituitary, and ovaries [43-45]. On the other hand, biallelic Gsalpha expression has been demonstrated in lymphocytes, adrenal, adipocytes, and bone cells [44, 46, 47]. The tissue-specific, imprinted expression of Gsalpha has important implications in the pathogenesis of diseases caused by mutations within GNAS, particularly pseudohypoparathyroidism (see below).
###end p 12
###begin p 13
###xml 96 103 88 95 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 573 575 553 555 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R48">48</xref>
###xml 576 578 556 558 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R51">51</xref>
###xml 25 30 <span type="species:ncbi:10090">mouse</span>
###xml 109 114 <span type="species:ncbi:10090">mouse</span>
###xml 198 203 <span type="species:ncbi:9606">human</span>
Several Gsalpha knockout mouse models have been generated in order to study the role of Gsalpha in vivo. The mouse models with universal Gsalpha disruption will be discussed below in the context of human diseases that are caused by heterozygous inactivating mutations within one of the 13 exons encoding this protein. In addition, Gsalpha has been conditionally ablated, through the use of the Cre-Flox technology, in specific tissues including liver, cartilage, bone, and glomerulus, confirming the absolute requirement of Gsalpha in the proper function of these tissues [48-51].
###end p 13
###begin title 14
###xml 37 41 37 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GNAS</italic>
NOVEL IMPRINTED GENE PRODUCTS OF THE GNAS LOCUS
###end title 14
###begin p 15
###xml 101 105 101 105 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GNAS</italic>
###xml 325 326 321 322 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">2</xref>
###xml 325 326 321 322 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="fig" rid="F2">2</xref></bold>
###xml 567 571 563 567 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GNAS</italic>
###xml 702 706 698 702 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GNAS</italic>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 10 15 <span type="species:ncbi:10090">mouse</span>
Human and mouse studies over the past several years have identified novel promoters and exons within GNAS, thereby unveiling the previously unrecognized complexity of this gene locus. The sense strand comprises at least three promoters besides the promoter driving the expression of the aforementioned Gsalpha variants (Fig. 2). In addition, there is at least one promoter that shows activity on the antisense strand. All of the recently described promoters are located within CpG islands that show differential, parent-of-origin specific methylation. Therefore, the GNAS locus harbors a total of four distinct DMRs. Consistent with the differential methylation of its promoter, each of the additional GNAS product shows an imprinted expression profile in nearly all tissues investigated in that regard.
###end p 15
###begin title 16
NESP55
###end title 16
###begin p 17
###xml 35 39 35 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GNAS</italic>
###xml 206 207 202 203 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">1</xref>
###xml 206 207 202 203 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="fig" rid="F1">1</xref></bold>
###xml 314 316 310 312 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R37">37</xref>
###xml 317 320 313 316 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R52"> 52</xref>
###xml 552 554 544 546 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R37">37</xref>
###xml 555 558 547 550 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R52"> 52</xref>
###xml 680 682 672 674 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R53">53</xref>
###xml 827 829 819 821 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R53">53</xref>
###xml 830 832 822 824 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R56">56</xref>
###xml 893 895 885 887 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R57">57</xref>
###xml 969 971 961 963 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R58">58</xref>
###xml 1208 1210 1200 1202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R59">59</xref>
###xml 1401 1403 1393 1395 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R58">58</xref>
###xml 1618 1620 1610 1612 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R53">53</xref>
###xml 326 332 <span type="species:ncbi:9606">humans</span>
###xml 387 391 <span type="species:ncbi:10090">mice</span>
The most upstream of the different GNAS promoters with respect to the promoter of Gsalpha drives the expression of NESP55, a neuroendocrine secretory protein with an apparent molecular mass of 55,000 (Fig. 1). The NESP55 promoter is differentially methylated and active on the non-methylated maternal allele only [37, 52]. In humans, NESP55 protein is encoded by a single exon, while in mice, the ORF consists of two separate exons; however, in both species, these exons splice onto Gsalpha exons 2-13, which comprise the 3' untranslated region (UTR) [37, 52]. The predicted molecular mass of NESP55 is 28 kDa, but it has the same electrophoretic mobility as a protein of 55 kDa [53]. NESP55 is a chromogranin-like protein expressed in neuroendocrine tissues, peripheral and central nervous system, and some endocrine tissues [53-56]. It is associated with the constitutive secretory pathway [57] and can be located in cholinergic, peptidergic, and adrenergic neurons [58]. In AtT20 cells, a corticotroph-like cell line, NESP55 has been shown to be exported out into the medium, a process which can be blocked markedly by lowering the temperature and modestly by treatment with a cAMP analog (8-bromo-cAMP) [59]. In different tissues, differential post-translational processing of NESP55 leads to smaller peptides, which appear to accumulate during antegrade transport of this protein along the axon [58]. One of the putative peptide products, Leu-Ser-Ala-Leu (LSAL), which may be produced by prohormone convertase cleavage, has been identified as an endogenous antagonist of the serotonergic 5-HT1B receptor subtype [53], although this possibility and its potential biological significance have yet to be investigated.
###end p 17
###begin p 18
###xml 182 184 182 184 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R60">60</xref>
###xml 319 323 319 323 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gnas</italic>
###xml 915 917 915 917 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R61">61</xref>
###xml 1310 1312 1310 1312 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R62">62</xref>
###xml 1313 1316 1313 1316 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R63"> 63</xref>
###xml 58 62 <span type="species:ncbi:10090">mice</span>
###xml 353 357 <span type="species:ncbi:10090">mice</span>
###xml 461 465 <span type="species:ncbi:10090">mice</span>
###xml 563 567 <span type="species:ncbi:10090">mice</span>
###xml 597 601 <span type="species:ncbi:10090">mice</span>
###xml 755 759 <span type="species:ncbi:10090">mice</span>
###xml 923 929 <span type="species:ncbi:9606">humans</span>
###xml 1035 1043 <span type="species:ncbi:9606">patients</span>
###xml 1219 1227 <span type="species:ncbi:9606">patients</span>
A knockout of the Nesp55 transcript has been generated in mice through introduction, by homologous recombination in ES cells, of a small deletion at the translation initiation site [60]. This mutation leads to a complete ablation of Nesp55 protein after maternal transmission, without affecting the expression of other Gnas transcripts. Nesp55 knockout mice appear to have no overt phenotypic abnormalities and are fertile. However, behavioral studies of these mice using several distinct tasks have revealed increased reactivity to novel environments, but these mice do not differ from wild-type mice in general locomotion and anxiety. Although the role of this protein at the molecular level remains to be explored, the findings in the Nesp55 deficient mice appear to be consistent with the localization of this protein in specific parts of the central nervous system, particularly noradrenergic locus coeruleus [61]. In humans, loss of NESP55 expression occurs as a result of a gain of methylation at its promoter (observed in some patients with pseudohypoparathyroidism type-Ib). This defect, however, does not appear to lead to an obvious phenotype, because no significant differences have been identified between patients with the gain of NESP55 methylation and those without this epigenetic alteration [62, 63].
###end p 18
###begin title 19
XLalphas
###end title 19
###begin p 20
###xml 171 172 163 164 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">1</xref>
###xml 171 172 163 164 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="fig" rid="F1">1</xref></bold>
###xml 288 290 272 274 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R36">36</xref>
###xml 291 294 275 278 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R52"> 52</xref>
###xml 514 516 482 484 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R64">64</xref>
###xml 616 618 580 582 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R36">36</xref>
###xml 619 622 583 586 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R52"> 52</xref>
###xml 749 751 709 711 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R36">36</xref>
###xml 752 755 712 715 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R52"> 52</xref>
###xml 756 759 716 719 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R65"> 65</xref>
###xml 874 876 830 832 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R47">47</xref>
###xml 1139 1141 1091 1093 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R36">36</xref>
###xml 1142 1145 1094 1097 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R64"> 64</xref>
###xml 1146 1149 1098 1101 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R66"> 66</xref>
###xml 1150 1153 1102 1105 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R67"> 67</xref>
###xml 1249 1251 1197 1199 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R68">68</xref>
###xml 1179 1182 <span type="species:ncbi:10116">rat</span>
Another promoter, located ~11 kb downstream of the NESP55 promoter, drives the expression of XLalphas mRNA, which encodes a protein with partial identity to Gsalpha (Fig. 1). As in NESP55, the XLalphas transcript uses a novel first exon (exon XL) that splices onto exons 2-13 of Gsalpha [36, 52]. Unlike in the case of NESP55, however, the in-frame termination codon for the XLalphas transcript is the same as for Gsalpha, making the encoded XLalphas and Gsalpha proteins identical over a long C-terminal stretch [64]. Exon XL and the XLalphas promoter are located in a CpG island methylated on the maternal allele [36, 52]. Consistent with this epigenetic mark, XLalphas is derived exclusively from the paternal allele in all investigated tissues [36, 52, 65]; however, variable biallelic expression of XLalphas has been recently demonstrated in clonal bone stromal cells [47]. Most abundant expression of XLalphas is detected in neuroendocrine tissues, particularly pituitary, but the expression of its mRNA is readily detected by Northern blot or RT-PCR in various tissues, including brain, pancreas, heart, kidney, and adipose tissue [36, 64, 66, 67]. As demonstrated in the rat nervous system, XLalphas expression is developmentally regulated [68].
###end p 20
###begin p 21
###xml 440 448 412 420 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 648 650 605 607 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R69">69</xref>
###xml 733 736 682 685 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">227</sup>
###xml 867 869 812 814 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R69">69</xref>
###xml 1019 1021 956 958 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R70">70</xref>
###xml 1134 1138 1063 1067 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gnas</italic>
###xml 1147 1149 1076 1078 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R71">71</xref>
###xml 1291 1293 1212 1214 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R70">70</xref>
###xml 1469 1470 1382 1383 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-</sup>
###xml 1479 1481 1392 1394 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R69">69</xref>
###xml 1634 1636 1539 1541 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R69">69</xref>
###xml 1030 1035 <span type="species:ncbi:10090">mouse</span>
Because XLalphas shares significant amino acid identity with Gsalpha, it comprises most domains of the latter shown to be functionally important. Furthermore, the C-terminal end of the XL domain has significant homology to the exon 1 encoded portion of Gsalpha. Consistent with the high degree of overall similarity between XLalphas and Gsalpha, various studies have demonstrated that XLalphas is able to act in a manner similar to Gsalpha in vitro. First, XLalphas show enhanced ADP ribosylation and an increased sucrose-density sedimentation rate upon addition of the Gbetagamma subunits, indicating that XLalphas is able to form a heterotrimer [69]. Second, expression of an XLalphas mutant carrying the homolog of the Gsalpha Gln227 mutation results in elevated cAMP formation, indicating that XLalphas can stimulate adenylyl cyclase at least in the basal state [69]. Third, XLalphas can mediate receptor-stimulated cAMP formation when overexpressed in opossum kidney cells that show endogenous Gsalpha expression [70] and in mouse embryonic fibroblasts that endogenously lack Gsalpha and XLalphas due to homozygous disruption of Gnas exon 2 [71]. Finally, mutations that impair Gsalpha activity have similar effects on XLalphas activity when introduced into the backbone of the latter [70]. Interestingly, however, beta-adrenergic stimulation seemingly fails to elicit cAMP generation in XLalphas transfected S49 lymphoma cells that are also Gsalpha deficient (cyc- clone) [69]. Furthermore, attempts to show coupling of XLalphas to receptors have failed, using PC12 cells transfected with XLalphas cDNA and pituitary membranes [69]. Taken together, these findings suggest that the Gsalpha-like activity of XLalphas may be cell specific.
###end p 21
###begin p 22
###xml 24 26 24 26 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">3A</xref>
###xml 24 26 24 26 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="fig" rid="F3">3A</xref></bold>
###xml 444 446 420 422 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R36">36</xref>
###xml 518 520 490 492 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R66">66</xref>
###xml 283 288 <span type="species:ncbi:9606">Human</span>
###xml 501 504 <span type="species:ncbi:10116">rat</span>
As illustrated in Fig. (3A), XLalphas has several different variants. Similar to Gsalpha, it uses exon 3 alternatively, thus having at least a long and a short variant. In addition, analogous to Gsalpha-N1, a C-terminally truncated XLalphas variant, termed XLalphas-N1, also exists. Human XLalphas-N1 appears to have a subvariant produced by inclusion of sequences from two additional exons, A20 and A21, located immediately following exon XL [36]. A similar subvariant has also been demonstrated for rat XLalphas-N1 [66]. The introduction of these additional sequences into XLalphas-N1 results in a frame-shift, leading to a putative protein with partial identity to XLalphas but not to Gsalpha. Functional significance of XLalphas-N1 and its variants remains unknown.
###end p 22
###begin p 23
###xml 125 127 117 119 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">3A</xref>
###xml 125 127 117 119 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="fig" rid="F3">3A</xref></bold>
###xml 271 273 255 257 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R72">72</xref>
###xml 378 380 358 360 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R67">67</xref>
###xml 346 351 <span type="species:ncbi:10090">mouse</span>
There is evidence for the existence of a long XLalphas transcript, termed XXLalphas, which extends in the 5' direction (Fig. 3A). The XXLalphas transcript is supported by Est databases and a single study that could amplify portions of the XXLalphas transcript by RT-PCR [72]. A long XLalphas transcript has also been revealed by Northern blot in mouse heart and adipose tissue [67]. In fact, based on existing data, the translation initiation codon for XLalphas does not match with that corresponding to the longest open reading frame (ORF), making it likely that an N-terminally extended XLalphas variant is expressed at least in some tissues. Est databases also suggest the existence of transcripts that correspond to XXLalphas-N1, but neither the role of XXLalphas nor the role of XXLalphas-N1 is currently known. Interestingly, however, unlike the XL domain in XLalphas and XLalphas-N1-- the portion encoded by exon XL -- the N-terminally extended part in XXLalphas and XXLalphas-N1 is highly conserved among mammals, suggesting that it may represent a functionally significant domain.
###end p 23
###begin p 24
###xml 81 83 77 79 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">al</underline>
###xml 101 102 97 98 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">e</underline>
###xml 112 113 108 109 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">X</underline>
###xml 229 231 217 219 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">3B</xref>
###xml 229 231 217 219 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="fig" rid="F3">3B</xref></bold>
###xml 234 242 222 230 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vitro</italic>
###xml 349 351 333 335 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R73">73</xref>
###xml 352 355 336 339 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R74"> 74</xref>
###xml 643 645 623 625 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R74">74</xref>
###xml 870 872 846 848 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R75">75</xref>
###xml 1126 1128 1086 1088 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R72">72</xref>
The XLalphas mRNA has a second ORF that encodes another protein termed ALEX (for alternative protein encoded by XLalphas mRNA), which uses a termination codon located within exon XL and is, therefore, smaller than XLalphas (Fig. 3B). In vitro studies have shown that ALEX, which has a predicted molecular mass of 38 kDa, can interact with XLalphas [73, 74]. An insertion polymorphism within XLalphas mRNA, affecting both proteins, appears to impair this interaction, a finding that has been offered as an explanation as to why some individuals carrying this insertion polymorphism show elevated agonist-induced cAMP accumulation in platelets [74]. However, this increased agonist responsiveness could also result from elevated Gsalpha levels, which was demonstrated in several individuals who carried the same insertion polymorphism and had increased bleeding tendency [75]. Hence, the significance of XLalphas-ALEX interaction on XLalphas or Gsalpha function remains to be clarified. Of note, this alternative ORF also extends in to the XXLalphas mRNA, generating a putative N-terminally extended ALEX variant, termed ALEXX [72]; however, there are currently no available experimental data to suggest that this protein actually exists.
###end p 24
###begin p 25
###xml 201 205 197 201 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gnas</italic>
###xml 219 221 215 217 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R67">67</xref>
###xml 293 297 285 289 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gnas</italic>
###xml 423 427 407 411 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gnas</italic>
###xml 567 571 551 555 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gnas</italic>
###xml 821 825 805 809 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gnas</italic>
###xml 1058 1060 1042 1044 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R67">67</xref>
###xml 1273 1275 1257 1259 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R76">76</xref>
###xml 1458 1460 1438 1440 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R76">76</xref>
###xml 30 34 <span type="species:ncbi:10090">mice</span>
###xml 228 232 <span type="species:ncbi:10090">mice</span>
###xml 309 313 <span type="species:ncbi:10090">mice</span>
###xml 583 587 <span type="species:ncbi:10090">mice</span>
###xml 905 909 <span type="species:ncbi:10090">mice</span>
###xml 1452 1456 <span type="species:ncbi:10090">mice</span>
Exon XL has been disrupted in mice through introduction of a small deletion into the beginning part of both XLalphas and ALEX ORF; this disruption appears to preserve the imprinted expression of other Gnas transcripts [67]. The mice with paternal inheritance of the disrupted XLalphas allele (Gnasxl knockout mice) lack XLalphas expression, consistent with the exclusive paternal expression of the XLalphas transcript. The Gnasxl knockout pups show defective suckling, hypoglycemia, growth retardation, and early postnatal mortality. Despite having hypoglycemia, the Gnasxl knockout mice show reduced glucagon levels and inappropriately normal serum catecholamine and cortisol levels, suggesting a possible impairment of the physiological responses to hypoglycemia. When crossed into the CD1 background, about 20% of the Gnasxl knockout animals survive with an apparently normal life-span. However, these mice display increased glucose tolerance and insulin sensitivity, as well as a hypermetabolic state associated with reduced adiposity and hypolipidemia [67]. In addition, circulating levels of norepinephrine is elevated in these animals, indicating increased sympathetic nervous system activity, which explains, at least in part, the defects in the energy metabolism [76]. On the other hand, adipocyte-autonomous factors appear less likely to be involved in these phenotypes, because XLalphas is not expressed in the adipocytes of adult wild-type mice [76].
###end p 25
###begin p 26
###xml 30 34 30 34 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gnas</italic>
###xml 203 207 187 191 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gnas</italic>
###xml 328 332 308 312 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gnas</italic>
###xml 352 354 332 334 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R77">77</xref>
###xml 355 357 335 337 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R79">79</xref>
###xml 428 430 408 410 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R80">80</xref>
###xml 431 434 411 414 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R81"> 81</xref>
###xml 547 551 519 523 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gnas</italic>
###xml 828 832 792 796 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gnas</italic>
###xml 930 934 894 898 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gnas</italic>
###xml 991 993 947 949 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R41">41</xref>
###xml 994 997 950 953 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R82"> 82</xref>
###xml 1009 1013 965 969 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gnas</italic>
###xml 1141 1143 1097 1099 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R67">67</xref>
###xml 46 50 <span type="species:ncbi:10090">mice</span>
###xml 219 223 <span type="species:ncbi:10090">mice</span>
###xml 309 313 <span type="species:ncbi:10090">mice</span>
###xml 366 370 <span type="species:ncbi:10090">mice</span>
###xml 563 567 <span type="species:ncbi:10090">mice</span>
###xml 688 693 <span type="species:ncbi:10090">mouse</span>
###xml 844 848 <span type="species:ncbi:10090">mice</span>
###xml 894 898 <span type="species:ncbi:10090">mice</span>
###xml 1025 1029 <span type="species:ncbi:10090">mice</span>
The genetic alteration in the Gnasxl knockout mice is predicted to disrupt not only XLalphas but also XLalphas-N1, ALEX, XXLalphas, XXLalphas-N1 and ALEXX. It thus appears unlikely that the phenotype of Gnasxl knockout mice is due solely to XLalphas deficiency. Nonetheless, a similar phenotype is present in mice with paternal Gnas exon 2 disruption [77-79] and in mice with a paternally inherited missense mutation in exon 6 [80, 81], thereby ruling out the involvement of ALEX, XLalphas-N1, and XXLalphas-N1 deficiency in the phenotypes of the Gnasxl knockout mice. Thus, it is more likely that the deficiency of XLalphas and/or XXLalphas underlies the findings observed in the latter mouse model, although this conclusion needs to be verified through further investigation. It is important to note that the phenotype of the Gnasxl knockout mice differs, by and large, from the phenotype of mice heterozygous for disruption of Gnas exon 1, in which Gsalpha, but not XLalphas, is ablated [41, 82]. In fact, Gnasxl knockout mice demonstrate slightly elevated basal and isoproterenol stimulated cAMP levels in brown adipose tissue at birth [67]. These findings suggest that XLalphas has a role distinct from the role of Gsalpha in mammals, and that it may oppose, at least in certain tissues, the actions of Gsalpha.
###end p 26
###begin p 27
###xml 51 55 51 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gnas</italic>
###xml 99 103 99 103 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gnas</italic>
###xml 237 241 237 241 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GNAS</italic>
###xml 249 251 249 251 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R83">83</xref>
###xml 473 477 473 477 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GNAS</italic>
###xml 613 617 609 613 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GNAS</italic>
###xml 67 71 <span type="species:ncbi:10090">mice</span>
###xml 80 84 <span type="species:ncbi:10090">mice</span>
###xml 158 166 <span type="species:ncbi:9606">children</span>
Findings that are reminiscent of those observed in Gnasxl knockout mice and the mice with paternal Gnas exon 2 disruption have been reported in two unrelated children with large paternal deletions of chromosome 20q13.3 that comprise the GNAS locus [83]. These findings included perinatal growth retardation, intractable feeding difficulties, and loss of subcutaneous adiposity, as well as dysmorphic facial features. Because the deletion involved, in each case, the entire GNAS locus, it is possible that the phenotype reflects, at least partially, the deficiency of Gsalpha and/or the other paternally expressed GNAS products (see below).
###end p 27
###begin title 28
The A/B Transcript
###end title 28
###begin p 29
###xml 171 173 167 169 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R84">84</xref>
###xml 174 176 170 172 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R86">86</xref>
###xml 392 393 384 385 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">2</xref>
###xml 392 393 384 385 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="fig" rid="F2">2</xref></bold>
###xml 605 613 589 597 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 634 636 618 620 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R86">86</xref>
###xml 902 904 882 884 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R86">86</xref>
About 2.5 kb upstream of the Gsalpha promoter lies another promoter that drives the nearly ubiquitous expression of another transcript termed A/B (also termed 1A and 1') [84-86]. The A/B promoter, despite being in close proximity to the Gsalpha promoter, reside within a DMR, where the maternal allele is methylated and repressed, while the paternal allele is non-methylated and active (Fig. 2). The first exon of the A/B transcript, as in NESP55 and XLalphas, splices onto Gsalpha exons 2-13. However, exon A/B does not contain an in-frame translation initiation codon, and as supported by evidence from in vitro translation assays [86], translation can be initiated by an in-frame AUG located in exon 2, leading, presumably, to a variant of Gsalpha that has a truncated N-terminus. Transfection of COS cells with A/B cDNA results in the expression of a protein that localizes to the plasma membrane [86]. Based on these features, it is conceivable that the A/B protein interacts with adenylyl cyclase and may, therefore, exert a dominant negative effect on Gsalpha actions. This possibility remains to be investigated.
###end p 29
###begin p 30
###xml 340 344 340 344 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GNAS</italic>
###xml 475 477 471 473 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R85">85</xref>
###xml 662 663 658 659 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sup>
###xml 716 717 712 713 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">9</sup>
###xml 741 743 737 739 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R42">42</xref>
###xml 744 747 740 743 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R87"> 87</xref>
###xml 945 947 933 935 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R81">81</xref>
###xml 948 951 936 939 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R88"> 88</xref>
###xml 1263 1265 1247 1249 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R63">63</xref>
###xml 1266 1269 1250 1253 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R89"> 89</xref>
###xml 1270 1273 1254 1257 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R90"> 90</xref>
###xml 1215 1223 <span type="species:ncbi:9606">patients</span>
On the other hand, it appears more likely that the A/B transcript is non-coding, as the existence of an endogenous A/B protein is not supported by experimental evidence. Furthermore, similar to other non-coding RNA molecules in the genome, the A/B transcript and/or the exon A/B DMR has an important role in regulating gene expression from GNAS. Unlike the DMRs comprising the promoters of NESP55 and XLalphas, the exon A/B DMR has been shown to be a germ-line imprint mark [85]. It has also been shown that this DMR is associated with allele-specific differences in histone modifications consistent with an active paternal (histone acetylation and histone-3 Lys4 methylation) and an inactive maternal (histone-3 Lys9 metyhlation) promoter [42, 87]. In addition, paternal ablation of the A/B DMR results in derepression of the Gsalpha transcript in those tissues where paternal Gsalpha expression is normally silenced, such as the renal cortex [81, 88]. Thus, it appears that the non-methylated A/B DMR and/or active A/B transcription is necessary for the tissue-specific paternal silencing of Gsalpha. Consistent with this finding, maternal exon A/B is unmethylated and the maternal A/B promoter is derepressed in patients with pseudohypoparathyroidism type-Ib [63, 89, 90], who are thought to have a lack of Gsalpha expression in the proximal tubule due to silencing of the maternal Gsalpha promoter (in addition to the silencing of the paternal Gsalpha promoter that occurs normally in the same tissue; see below for further discussion).
###end p 30
###begin p 31
###xml 749 751 733 735 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R91">91</xref>
###xml 752 755 736 739 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R92"> 92</xref>
###xml 843 848 <span type="species:ncbi:10090">mouse</span>
The mechanisms underlying the role of A/B in the tissue-specific silencing of paternal Gsalpha expression are not well understood. Considering that the A/B transcription takes place more broadly than does paternal Gsalpha silencing, a mechanism that involves simple competition between the promoters of these two transcripts is unlikely. On the other hand, a plausible hypothesis involves a mechanism whereby the paternal A/B DMR binds either a repressor that directly silences the Gsalpha promoter or an insulator that prevents the effects of an upstream enhancer on the Gsalpha promoter. A mechanism similar to the latter has been demonstrated for the Igf2-H19 locus, in which methylation-sensitive binding of CTCF hinders Igf2 enhancer activity [91, 92]. To address these possibilities, it may be necessary to generate and study additional mouse models in which A/B transcript is disrupted without the deletion of its promoter region.
###end p 31
###begin title 32
###xml 4 8 4 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GNAS</italic>
The GNAS Antisense Transcript
###end title 32
###begin p 33
###xml 159 161 155 157 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R93">93</xref>
###xml 162 165 158 161 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R94"> 94</xref>
###xml 173 174 169 170 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">2</xref>
###xml 173 174 169 170 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="fig" rid="F2">2</xref></bold>
###xml 236 240 232 236 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gnas</italic>
###xml 310 312 306 308 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R94">94</xref>
###xml 368 370 364 366 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R93">93</xref>
###xml 432 436 428 432 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GNAS</italic>
###xml 646 648 642 644 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R93">93</xref>
###xml 794 798 790 794 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GNAS</italic>
###xml 885 887 881 883 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R65">65</xref>
###xml 888 891 884 887 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R93"> 93</xref>
###xml 892 895 888 891 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R94"> 94</xref>
###xml 986 988 982 984 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R65">65</xref>
###xml 1122 1123 1118 1119 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sup>
###xml 1216 1217 1212 1213 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">9</sup>
###xml 1231 1233 1227 1229 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R87">87</xref>
###xml 1416 1418 1412 1414 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R95">95</xref>
###xml 180 184 <span type="species:ncbi:10090">mice</span>
###xml 324 330 <span type="species:ncbi:9606">humans</span>
###xml 426 431 <span type="species:ncbi:9606">human</span>
###xml 1260 1264 <span type="species:ncbi:10090">mice</span>
A promoter located immediately upstream of the XLalphas promoter drives expression of an antisense transcript, which extends past the exon(s) encoding NESP55 [93, 94] (Fig. 2). In mice, the mature antisense transcript (termed Nespas or Gnasas) encompasses both Nesp55 exons 1 and 2 and the intervening intron [94], while in humans, it has no overlap with exon NESP55 [93]. There are at least five distinct exons that form the human GNAS antisense transcript, but alternative splicing results in at least six variants. The largest open reading frame is predicted to encode a polypeptide of 97 amino acids that share no homology to known proteins [93]. Taken together these features suggest that the antisense transcript is non-coding. Indeed, similar to the promoter of A/B, the promoter of the GNAS antisense promoter resides in a DMR and is active exclusively on the paternal allele [65, 93, 94]; however, the antisense transcript shows biallelic expression in the adrenal and testes [65]. Consistent with allele-specific expression, the paternal antisense promoter is associated with acetylated histone and histone-3 Lys4 methylation, while the maternal promoter lacks histone acetylation and carries histone-3 Lys9 methylation [87]. Furthermore, studies in mice have shown that the maternal methylation at the antisense promoter is present even in the oocytes and, therefore, represents a germ-line imprint mark [95].
###end p 33
###begin p 34
###xml 86 92 86 92 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in cis</italic>
###xml 149 151 149 151 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R96">96</xref>
###xml 571 575 563 567 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gnas</italic>
###xml 911 917 895 901 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in cis</italic>
###xml 1109 1113 1089 1093 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GNAS</italic>
###xml 47 51 <span type="species:ncbi:10090">mice</span>
###xml 587 591 <span type="species:ncbi:10090">mice</span>
###xml 601 605 <span type="species:ncbi:10090">mice</span>
Paternal deletion of the antisense promoter in mice results in derepression of Nesp55 in cis, thereby leading to biallelic expression of the latter [96]. This finding indicates that at least one of the roles of the antisense transcript is to silence the paternal Nesp55 promoter. However, the effect of the deletion of the antisense promoter is not limited to Nesp55 expression. First, the deleted region evidently comprises an enhancer of the XLalphas promoter, resulting in a dramatic reduction in XLalphas expression and, thus, a phenotype similar to that observed in Gnasxl knockout mice. Second, mice with the paternal deletion exhibit a modest decrease in A/B expression combined with an increase in the methylation of the A/B promoter. Third, in those tissues where Gsalpha is normally silenced from the paternal allele, the diminished A/B expression is associated with an increase in Gsalpha expression in cis, i.e. the tissue specific Gsalpha imprinting is relaxed. These findings clearly demonstrate the importance of the antisense transcript in the regulation of imprinted gene expression from the GNAS locus. Nonetheless, what causes the reduction of paternal A/B expression remains unclear. Is it the derepression of Nesp55, the reduction of XLalphas expression, or the deletion of the genomic region containing the antisense promoter?
###end p 34
###begin title 35
###xml 31 35 31 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GNAS</italic>
HUMAN DISEASES ASSOCIATED WITH GNAS MUTATIONS
###end title 35
###begin p 36
###xml 401 405 385 389 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gnas</italic>
###xml 416 420 400 404 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gnas</italic>
###xml 429 431 413 415 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R40">40</xref>
###xml 432 435 416 419 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R41"> 41</xref>
###xml 436 439 420 423 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R82"> 82</xref>
###xml 146 151 <span type="species:ncbi:9606">human</span>
###xml 359 363 <span type="species:ncbi:10090">mice</span>
Consistent with the pivotal role of Gsalpha in multiple biological responses, mutations that affect the activity or expression of Gsalpha lead to human disease. However, there are no disorders caused by inactivation of both Gsalpha alleles, i.e. homozygous inactivating Gsalpha mutations, and this is consistent with the early embryonic lethality observed in mice with homozygous disruption of either Gnas exon 2 or Gnas exon 1 [40, 41, 82]. Thus, complete loss of Gsalpha activity is not compatible with life. Moreover, there are mutations that cause constitutive Gsalpha activity, but these are virtually never inherited and are of somatic origin, indicating that universal Gsalpha overactivity is embryonic lethal, as well.
###end p 36
###begin title 37
Endocrine Adenomas and other Tumors
###end title 37
###begin p 38
###xml 474 477 462 465 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">201</sup>
###xml 484 487 472 475 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">227</sup>
###xml 577 579 565 567 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R20">20</xref>
###xml 580 583 568 571 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R97"> 97</xref>
###xml 724 727 704 707 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">gsp</italic>
###xml 738 740 718 720 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R20">20</xref>
###xml 741 744 721 724 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R97"> 97</xref>
###xml 784 787 764 767 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">gsp</italic>
###xml 971 973 951 953 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R98">98</xref>
###xml 1019 1022 999 1002 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">gsp</italic>
###xml 1181 1183 1161 1163 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R99">99</xref>
###xml 1184 1188 1164 1168 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R100"> 100</xref>
###xml 1354 1357 1330 1333 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R101">101</xref>
###xml 1371 1374 1347 1350 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">gsp</italic>
###xml 1676 1679 1648 1651 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R102">102</xref>
###xml 1680 1684 1652 1656 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R103"> 103</xref>
###xml 1825 1828 1797 1800 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R104">104</xref>
###xml 1872 1875 1844 1847 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">gsp</italic>
###xml 349 357 <span type="species:ncbi:9606">patients</span>
###xml 898 905 <span type="species:ncbi:9606">patient</span>
###xml 1223 1231 <span type="species:ncbi:9606">patients</span>
###xml 1517 1522 <span type="species:ncbi:10090">mouse</span>
Many hormones bind Gsalpha-coupled receptors in order to activate their endocrine glands for proliferation, differentiation, and hormone secretion. Accordingly, mutations that cause constitutive Gsalpha activity are found in various functionally active endocrine adenomas, including those that originate from pituitary somatotrophs. In about 40% of patients with growth hormone secreting pituitary adenomas, constitutively activating Gsalpha missense mutations at either Arg201 or Gln227 have been identified in DNA from the tumor tissue, but not in DNA from peripheral blood [20, 97]. Since these mutant Gsalpha forms are identified in tumors and are present in one of the Gsalpha alleles only, they are referred to as the gsp oncogene [20, 97]. Other endocrine tumors also bare the gsp oncogene, including corticotroph, thyroid, parathyroid, and adrenocortical tumors, but their frequency in the patient population appears to be low based on many studies (reviewed in [98]). Some studies have recently identified the gsp oncogene in ovarian granulosa cell tumors and testicular stromal Leydig cell tumors as a possible cause of tumorigenesis and as a possible prognostic marker [99, 100]. In a more recent study, 5 of 30 patients with clear cell renal carcinoma have been shown to carry constitutively activating Gsalpha mutations in the tumor tissue [101]. Hence, the gsp oncogene can be present in a wide variety of tumors that mostly, but not exclusively, involve classic endocrine tissues. Data from transgenic mouse models and cell culture assays have shown that constitutive Gsalpha activity can lead to hyperplasia and increased hormone secretion in endocrine cells [102, 103]. However, although a recent study implicates sustained activation of extracellular signal-regulated kinase in increased hormone secretion [104], the signaling pathways downstream of the gsp oncogene currently remain incompletely understood.
###end p 38
###begin title 39
McCune-Albright Syndrome
###end title 39
###begin p 40
###xml 50 53 50 53 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R105">105</xref>
###xml 68 73 68 73 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 76 79 76 79 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R106">106</xref>
###xml 372 375 368 371 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R107">107</xref>
###xml 376 379 372 375 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R109">109</xref>
###xml 543 546 539 542 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">201</sup>
###xml 599 602 595 598 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">227</sup>
###xml 1243 1246 1235 1238 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R110">110</xref>
###xml 1247 1251 1239 1243 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R111"> 111</xref>
###xml 1346 1350 1338 1342 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GNAS</italic>
###xml 1367 1370 1359 1362 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">201</sup>
###xml 1480 1483 1472 1475 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">227</sup>
###xml 1532 1535 1524 1527 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R112">112</xref>
###xml 1735 1738 1727 1730 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R106">106</xref>
###xml 1739 1743 1731 1735 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R109"> 109</xref>
###xml 1931 1934 1923 1926 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R113">113</xref>
###xml 1935 1938 1927 1930 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R115">115</xref>
###xml 2091 2094 2083 2086 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R113">113</xref>
###xml 2095 2099 2087 2091 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R114"> 114</xref>
###xml 2386 2389 2374 2377 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R116">116</xref>
###xml 2390 2393 2378 2381 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R118">118</xref>
###xml 2842 2844 2830 2832 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R98">98</xref>
###xml 217 225 <span type="species:ncbi:9606">Patients</span>
###xml 705 713 <span type="species:ncbi:9606">patients</span>
###xml 957 965 <span type="species:ncbi:9606">patients</span>
###xml 1110 1118 <span type="species:ncbi:9606">patients</span>
###xml 1260 1268 <span type="species:ncbi:9606">patients</span>
###xml 1946 1954 <span type="species:ncbi:9606">patients</span>
###xml 2305 2313 <span type="species:ncbi:9606">patients</span>
###xml 2530 2538 <span type="species:ncbi:9606">patients</span>
This syndrome, independently described by McCune [105] and Albright et al. [106], is characterized by a triad of sexual precocity, fibrous dysplasia of bone, and hyperpigmented skin lesions termed cafe-au-lait spots. Patients with the McCune-Albright syndrome (MAS) are mosaic for constitutively activating Gsalpha mutations that occur during early embryonic development [107-109]. This is consistent with the observation that MAS occurs sporadically and is never transmitted to the next generation. All identified mutations are at residue Arg201 (Cys or His), suggesting that changes in residue Gln227 may result in higher constitutive activity and are, therefore, less viable. Because of the mosaicism, patients with MAS show significant variation in their clinical presentation. In general, the abnormalities involve bone, skin, and endocrine organs. Fibrous dysplastic bone lesions are usually found in multiple bones. It is important to note that some patients with the constitutively activating Gsalpha mutations present with fibrous dysplasia alone, affecting either a single bone or multiple bones. In patients with isolated fibrous dysplasia, histological changes appear to be indistinguishable form those seen in the context of MAS [110, 111]. As in patients with MAS, nearly all isolated cases of fibrous dysplasia are associated with GNAS mutations at Arg201; however, a study using a mutation-specific restriction enzyme digest assay has recently identified three Gln227 (to Leu) mutations among a total of 56 samples [112]. The skin lesions, which typically have irregular borders, can be single or multiple light brown hyperpigmented areas arranged in segmental patterns that follow the developmental lines of Blaschko [106, 109]. Endocrine abnormalities, in addition to precocious puberty, can be summarized as hyperplasia and increased function of many different glands, including thyroid, adrenal, and pituitary [113-115]. Some patients with MAS also exhibit urinary phosphate wasting, hypophosphatemia, and bone mineralization defects observed as rickets or osteomalacia [113, 114]. While the latter findings are consistent with the role of Gsalpha in mediating the phosphaturic actions of parathyroid hormone in the renal proximal tubule, recent data shows that serum phosphate in MAS patients is negatively correlated with the level of fibroblast growth factor-23 [116-118], suggesting that the elevation of this phosphaturic factor is responsible, at least partly, for the hypophosphatemia observed in these patients. In addition to the various endocrine defects discussed above, there are rare reports of non-endocrine abnormalities associated with MAS, including liver and cardiac abnormalities, and neurological defects. The endocrine and non-endocrine findings in MAS have been reviewed elsewhere in greater detail [98].
###end p 40
###begin title 41
Pseudohypoparathyroidism Type-Ia, Pseudopseudohypoparathyroidism, and Progressive Osseous Heteroplasia
###end title 41
###begin p 42
###xml 43 46 43 46 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R119">119</xref>
###xml 354 357 354 357 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R120">120</xref>
###xml 358 362 358 362 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R121"> 121</xref>
###xml 454 457 454 457 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R122">122</xref>
###xml 458 462 458 462 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R123"> 123</xref>
###xml 694 698 694 698 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">via </italic>
###xml 815 818 815 818 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R124">124</xref>
###xml 1074 1077 1074 1077 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R119">119</xref>
###xml 1078 1082 1078 1082 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R125"> 125</xref>
Fist described by Albright and colleagues [119], Pseudohypoparathyroidism (PHP) refers to end-organ resistance to multiple hormones that primarily involves the actions of parathyroid hormone. PTH exerts its actions in bone and kidney through the PTH/parathyroid hormone-related peptide receptor (PTHR1), which couples to Gs and, less effectively, to Gq [120, 121]. PTH increases bone turnover, leading to mobilization of calcium and phosphate from bone [122, 123]. In the proximal renal tubule, it induces the synthesis of 1,25-dihydroxyvitamin D and inhibits phosphate reabsorption from the glomerular filtrate, while in the distal renal tubule, it enhances the absorption of calcium mediated via transcellular mechanisms. Exogenous administration of biologically active PTH, used previously as a diagnostic test [124], results in a blunted excretion of urinary phosphate in both PHP type-I and PHP type-II, but this defect is accompanied by blunted nephrogenous cAMP production in PHP type-I only; the PTH-induced generation of nephrogenous cAMP is normal in PHP type-II [119, 125]. Clinically, PHP-I is far more frequent than PHP-II, for which underlying molecular defects are not well understood. On the other hand, significant advances have been recently made regarding the molecular pathology underlying PHP-I.
###end p 42
###begin p 43
###xml 121 124 121 124 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R119">119</xref>
###xml 525 528 521 524 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R126">126</xref>
###xml 529 532 525 528 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R128">128</xref>
###xml 638 642 630 634 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GNAS</italic>
###xml 650 653 642 645 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R129">129</xref>
###xml 654 658 646 650 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R130"> 130</xref>
###xml 976 1003 968 995 <uri xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:type="simple" xlink:href="http://www.ncbi.nlm.nih.gov">http://www.ncbi.nlm.nih.gov</uri>
###xml 5 13 <span type="species:ncbi:9606">patients</span>
###xml 270 277 <span type="species:ncbi:9606">patient</span>
###xml 281 288 <span type="species:ncbi:9606">patient</span>
###xml 396 404 <span type="species:ncbi:9606">patients</span>
###xml 515 523 <span type="species:ncbi:9606">patients</span>
Some patients with PHP-I display distinctive physical features collectively termed Albright's hereditary osteodystrophy [119]. These features include obesity, short stature, ectopic ossification, brachydactyly, and mild mental retardation, although there is significant patient-to-patient variation in the range and severity of these features. The presence of both PTH-resistance and AHO defines patients with PHP type-Ia. Gsalpha mRNA and protein levels are reduced to half in easily accessible tissues from these patients [126-128]. This defect results from heterozygous inactivating mutations within one of the thirteen Gsalpha coding GNAS exons [129, 130]. Scattered throughout the gene, various different types of mutations, such as insertions, deletions, and missense and nonsense changes, have been identified, which is consistent with their inactivating nature. An extensive list of the mutations associated with this disorder can be found under OMIM entry #139320 at http://www.ncbi.nlm.nih.gov.
###end p 43
###begin p 44
###xml 260 263 252 255 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R131">131</xref>
###xml 264 267 256 259 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R135">135</xref>
###xml 415 418 403 406 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R136">136</xref>
###xml 419 423 407 411 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R137"> 137</xref>
###xml 483 486 471 474 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R134">134</xref>
###xml 487 491 475 479 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R136"> 136</xref>
###xml 492 496 480 484 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R138"> 138</xref>
###xml 59 67 <span type="species:ncbi:9606">patients</span>
Because Gsalpha is not exclusive for PTH signaling, PHP-Ia patients also show resistance to some other hormones whose actions depend on Gsalpha signaling, including thyroid stimulating hormone (TSH), gonadotropins, and growth hormone releasing hormone (GHRH) [131-135]. It is worth noting that not all hormone actions that rely on Gsalpha are impaired in PHP-Ia. For example, there is no resistance to vasopressin [136, 137] or to hormones in the hypothalomo-pituitary-adrenal axis [134, 136, 138].
###end p 44
###begin p 45
###xml 210 213 206 209 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R139">139</xref>
###xml 361 364 357 360 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R129">129</xref>
###xml 365 369 361 365 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R140"> 140</xref>
###xml 553 556 549 552 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R141">141</xref>
###xml 557 561 553 557 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R142"> 142</xref>
###xml 47 55 <span type="species:ncbi:9606">patients</span>
###xml 76 84 <span type="species:ncbi:9606">patients</span>
###xml 229 237 <span type="species:ncbi:9606">patients</span>
###xml 287 295 <span type="species:ncbi:9606">patients</span>
Inactivating Gsalpha mutations found in PHP-Ia patients are also present in patients who lack hormone resistance but present with AHO features, a condition referred to as pseudopseudohypoparathyroidism (PPHP) [139]. Mutations in patients with PPHP are often identical to those in PHP-Ia patients. In fact, both disorders typically co-exist in the same kindred [129, 140], with the gender of the affected parent determining whether the offspring will have PHP-Ia or PPHP: maternal inheritance leads to PHP-Ia, whereas paternal inheritance leads to PPHP [141, 142]. Thus, hormone resistance (PHP-Ia) is inherited only from female obligate carriers, a mode of inheritance that is consistent with the predominantly maternal expression of Gsalpha in certain tissues. It is important to note that the repertoire of hormone resistance in PHP-Ia correlates well with the tissues in which maternal, monoallelic Gsalpha expression takes place, underscoring the significance of Gsalpha imprinting in the pathogenesis of PHP-Ia.
###end p 45
###begin p 46
###xml 366 370 358 362 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gnas</italic>
###xml 379 382 371 374 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R143">143</xref>
###xml 1097 1100 1073 1076 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R144">144</xref>
###xml 1317 1321 1289 1293 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GNAS</italic>
###xml 1430 1434 1402 1406 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gnas</italic>
###xml 1568 1572 1536 1540 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gnas</italic>
###xml 1592 1595 1560 1563 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R143">143</xref>
###xml 49 57 <span type="species:ncbi:9606">patients</span>
###xml 255 259 <span type="species:ncbi:10090">mice</span>
###xml 809 817 <span type="species:ncbi:9606">patients</span>
###xml 1068 1076 <span type="species:ncbi:9606">patients</span>
###xml 1087 1095 <span type="species:ncbi:9606">patients</span>
###xml 1667 1675 <span type="species:ncbi:9606">patients</span>
AHO features are present in both PHP-Ia and PPHP patients, and therefore, the molecular mechanisms underlying AHO presumably entail Gsalpha haploinsufficiency rather than imprinting. Gsalpha haploinsufficiency has been demonstrated in the growth plate of mice chimeric for wild-type cells and cells heterozygous for disruption of either the maternal or the paternal Gnas exon 2 [143]. In the chimeric setting, the mutant chondrocytes undergo hypertrophic differentiation sooner than wild-type chondrocytes, and because this finding is qualitatively similar to (albeit far less severe than) that observed in chondrocytes with homozygous Gsalpha ablation under the same conditions, it indicates Gsalpha haploinsufficiency. While this study strongly suggests that the short stature and the brachydactyly seen in patients with AHO reflect, at least in part, Gsalpha haploinsufficiency in the growth plate, some features of AHO may still involve Gsalpha imprinting in the pathogenesis. For example, a recent study has clearly shown that obesity is more prominent in PHP-Ia patients than PPHP patients [144]. Thus, it appears that Gsalpha may be imprinted in more tissues than currently recognized, such as in parts of the brain that controls satiety and body weight. It is also possible that disruption of other imprinted GNAS gene products contribute to the pathogenesis of AHO. Supporting this hypothesis, chondrocytes with paternal Gnas exon 2 disruption exhibit a slightly, but significantly, higher degree of Gsalpha haploinsufficiency than chondrocytes with maternal Gnas exon 2 disruption [143]. More detailed characterization of the different AHO features between patients with paternally and maternally inherited Gsalpha mutations are likely to provide further insights into the understanding of the mechanisms underlying AHO.
###end p 46
###begin p 47
###xml 233 236 233 236 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R145">145</xref>
###xml 301 305 297 301 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GNAS</italic>
###xml 455 458 451 454 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R145">145</xref>
###xml 459 462 455 458 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R147">147</xref>
###xml 692 695 688 691 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R146">146</xref>
###xml 696 700 692 696 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R148"> 148</xref>
###xml 811 814 807 810 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R147">147</xref>
###xml 959 963 955 959 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GNAS</italic>
###xml 1215 1218 1203 1206 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R147">147</xref>
###xml 1219 1223 1207 1211 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R149"> 149</xref>
###xml 1224 1228 1212 1216 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R150"> 150</xref>
###xml 1282 1286 1266 1270 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GNAS</italic>
###xml 341 349 <span type="species:ncbi:9606">patients</span>
###xml 425 433 <span type="species:ncbi:9606">patients</span>
Progressive osseous heteroplasia (POH) describes a severe, debilitating disease characterized by ectopic intramembranous bone formation that affects not only the subcutis, but also the skeletal muscle and the deep connective tissue [145]. Heterozygous inactivation mutations within the Gsalpha coding GNAS exons have also been identified in patients with POH. In fact, some of those mutations are identical to those found in patients with PHP-Ia or PPHP [145-147]. It is therefore possible that POH is an extreme manifestation of the ectopic bone formation of AHO that normally involves the subcutaneous tissue. However, POH is rarely accompanied with any AHO features or hormone resistance [146, 148]. Furthermore, in many kindreds, it has been shown that the disease develops only after paternal inheritance [147], suggesting that genomic imprinting also plays a role in the pathogenesis of POH. Because this disorder is paternally inherited, deficiency of GNAS products that show paternal specific expression and share exons with Gsalpha, such as XLalphas, could contribute to ectopic bone formation. Consistent with this hypothesis, no mutations in exon 1 has thus far been reported in cases with isolated POH [147, 149, 150]. However, the roles of XLalphas and other imprinted GNAS products in POH remain currently undefined.
###end p 47
###begin title 48
PHP Type-Ib
###end title 48
###begin p 49
###xml 257 259 257 259 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R89">89</xref>
###xml 260 263 260 263 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R90"> 90</xref>
###xml 264 268 264 268 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R151"> 151</xref>
###xml 428 431 428 431 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R152">152</xref>
###xml 628 632 620 624 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GNAS</italic>
###xml 640 643 632 635 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R131">131</xref>
###xml 644 648 636 640 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R153"> 153</xref>
###xml 800 803 792 795 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R154">154</xref>
###xml 1127 1129 1115 1117 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R70">70</xref>
###xml 1304 1308 1292 1296 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">null</italic>
###xml 1333 1335 1317 1319 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R70">70</xref>
###xml 1336 1339 1320 1323 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R71"> 71</xref>
###xml 1471 1474 1455 1458 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R154">154</xref>
###xml 1604 1607 1588 1591 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R131">131</xref>
###xml 1745 1748 1729 1732 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R153">153</xref>
###xml 1749 1753 1733 1737 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R155"> 155</xref>
###xml 1754 1757 1738 1741 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R157">157</xref>
###xml 5 13 <span type="species:ncbi:9606">patients</span>
###xml 187 195 <span type="species:ncbi:9606">patients</span>
###xml 317 325 <span type="species:ncbi:9606">patients</span>
###xml 571 579 <span type="species:ncbi:9606">patients</span>
###xml 681 689 <span type="species:ncbi:9606">patients</span>
###xml 1276 1281 <span type="species:ncbi:10090">mouse</span>
###xml 1367 1375 <span type="species:ncbi:9606">patients</span>
###xml 1594 1602 <span type="species:ncbi:9606">patients</span>
Some patients with PTH-resistance lack AHO and any additional hormone resistance, defining the typical features of PHP type-Ib (PHP-Ib). Recent studies have demonstrated that some PHP-Ib patients also have mild TSH resistance in addition to PTH resistance [89, 90, 151]. Furthermore, a single study described several patients who showed both the epigenetic defects characteristic of PHP-Ib (see below) and mild features of AHO [152], suggesting more variation in the phenotype. Unlike in PHP-Ia, Gsalpha activity is typically normal in easily accessible cells from these patients, thus excluding mutations within Gsalpha coding GNAS exons [131, 153]. Nonetheless, in three related patients with an apparent diagnosis of PHP-Ib an in-frame, tri-nucleotide deletion has been identified within exon 13 [154]. Expressed in HEK293 cells, an embryonic kidney derived cell line, this Gsalpha mutant was shown to affect the signaling of PTH, but not of TSH, LH, or isoproterenol, thus explaining the isolated PTH resistance. The selective effect of this mutation on PTH signaling, however, could not be verified in a subsequent study [70], and it is possible that the discrepancy between the two studies stems from the use of different cell types and/or assays; the second study used mouse embryonic fibroblasts null for endogenous Gsalpha [70, 71]. Alternatively, the three patients may have PHP-Ia, consistent with the observation that two of them exhibited advanced bone age [154], which is a typical sign of AHO. Since the urinary cAMP response to exogenously administered PTH is blunted in PHP-Ib patients [131], defects in the gene encoding PTHR1 seemed like a good candidate at the time. However, several studies have ruled out this possibility [153, 155-157].
###end p 49
###begin p 50
###xml 240 243 240 243 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R158">158</xref>
###xml 472 476 472 476 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GNAS</italic>
###xml 484 487 484 487 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R158">158</xref>
###xml 488 492 488 492 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R159"> 159</xref>
###xml 534 538 534 538 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GNAS</italic>
###xml 559 561 559 561 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R63">63</xref>
###xml 562 565 562 565 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R89"> 89</xref>
###xml 608 612 608 612 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GNAS</italic>
###xml 864 866 864 866 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R89">89</xref>
###xml 867 871 867 871 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R160"> 160</xref>
###xml 1001 1005 1001 1005 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GNAS</italic>
###xml 1165 1168 1165 1168 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R160">160</xref>
###xml 1169 1172 1169 1172 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R163">163</xref>
###xml 1180 1181 1180 1181 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">4</xref>
###xml 1180 1181 1180 1181 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="fig" rid="F4">4</xref></bold>
###xml 1259 1264 1259 1264 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">STX16</italic>
###xml 1385 1390 1385 1390 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">STX16</italic>
###xml 1493 1496 1493 1496 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R164">164</xref>
###xml 1789 1792 1789 1792 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R160">160</xref>
###xml 1793 1797 1793 1797 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R164"> 164</xref>
###xml 2031 2034 2031 2034 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R160">160</xref>
###xml 2144 2149 2144 2149 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">STX16</italic>
###xml 2184 2189 2184 2189 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">STX16</italic>
###xml 2312 2315 2312 2315 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R160">160</xref>
###xml 2316 2320 2316 2320 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R164"> 164</xref>
###xml 517 525 <span type="species:ncbi:9606">patients</span>
PHP-Ib is often sporadic, but a number of familial cases have also been described. A careful analysis of these pedigrees has revealed that the PTH resistance in PHP-Ib develops only if the genetic defect is inherited from a female carrier [158], i.e. the mode of inheritance is identical to that observed for hormone resistance in PHP-Ia. Genetic linkage studies using some of these kindreds have mapped the genetic defect to a region of chromosome 20q that comprises the GNAS locus [158, 159]. Moreover, most PHP-Ib patients exhibit GNAS imprinting defects [63, 89]. Although these defects involve multiple GNAS DMRs in some cases, the most consistent defect is a loss of imprinting at the A/B DMR, i.e. loss of methylation at the A/B promoter and exon combined with biallelic A/B expression, which appears to be an isolated defect in most familial PHP-Ib cases [89, 160]. Based on these findings, the genetic mutation responsible for PHP-Ib is thought to disrupt an imprinting regulatory element of GNAS. The most frequent mutation, identified thus far in more than 30 unrelated kindreds, is a unique 3-kb microdeletion located about 220 kb upstream of exon A/B [160-163] (Fig. 4). Flanked by two 391-bp repeats, the 3-kb microdeletion removes exons 4-6 of STX16, the gene encoding syntaxin-16. The second mutation is a 4.4-kb microdeletion that overlaps with the former and removes STX16 exons 2-4; this mutation, unlike the 3-kb microdeletion, has been found in only one kindred thus far [164]. These mutations cause disease only after maternal inheritance, and each affected individual carrying either of these mutations displays an isolated loss of exon A/B imprinting, thereby indicating that the mutations disrupt a cis-acting element that controls imprinting at the exon A/B DMR [160, 164]. This element may lie within the 1.3-kb region where the two deletions overlap. The overlapping region comprises exon 4, which is evolutionarily conserved and lies within a small CpG-rich region that lacks differential methylation [160]. It is also possible that the identified deletions independently disrupt a large control element that spans STX16. On the other hand, disruption of STX16 is not considered to be involved in the pathogenesis of PHP-Ib, because there is no evidence that this gene is imprinted [160, 164].
###end p 50
###begin p 51
###xml 83 87 83 87 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GNAS</italic>
###xml 126 128 126 128 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R63">63</xref>
###xml 129 132 129 132 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R89"> 89</xref>
###xml 334 338 334 338 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GNAS</italic>
###xml 498 501 498 501 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R165">165</xref>
###xml 614 618 614 618 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GNAS</italic>
###xml 632 633 632 633 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">4</xref>
###xml 632 633 632 633 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="fig" rid="F4">4</xref></bold>
###xml 752 755 752 755 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R165">165</xref>
All sporadic and some familial PHP-Ib cases show epigenetic defects at one or more GNAS DMRs in addition to the exon A/B DMR [63, 89]. These defects often consist of a loss of imprinting at exon A/B, exon XL, and the promoter of the antisense transcript and a gain of imprinting at exon NESP55. Two unrelated familial cases with such GNAS imprinting abnormalities have been shown to carry maternally inherited deletions of the entire NESP55 DMR including exons 3 and 4 of the antisense transcript [165], revealing the putative location of another control element required for the imprinting of the entire maternal GNAS allele (Fig. 4). The presence of similarly large deletions at the NESP55 DMR has been excluded in a number of sporadic PHP-Ib cases [165].
###end p 51
###begin p 52
###xml 10 14 10 14 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GNAS</italic>
###xml 270 272 270 272 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R90">90</xref>
###xml 963 966 963 966 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R162">162</xref>
###xml 1053 1057 1053 1057 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GNAS</italic>
###xml 397 404 <span type="species:ncbi:9606">patient</span>
The broad GNAS epigenetic defects seen in the sporadic cases are often such that the maternal allele has attained a paternal epigenotype. Accordingly, a sporadic PHP-Ib case has been shown to have paternal uniparental isodisomy of the entire chromosome 20q (patUPD20q) [90]. Leading to the diagnosis were PTH-resistance and mild TSH resistance in the absence of typical AHO findings, although the patient had additional abnormalities, including developmental delay and craniosynostosis, which may have resulted from either disrupted expression of other imprinted genes or from unmasking of recessive defects present on paternal chromosome 20q. Hence, patUPD20q is a cause of sporadic PHP-Ib, and it is possible that interstitial paternal UPDs in this region could lead to PHP-Ib as a more common cause of this disorder in the sporadic cases. It has also been suggested that some cases of sporadic PHP-Ib is caused by stochastic defects in the imprinting process [162]. In either case, the offspring of affected females would be predicted to have normal GNAS imprinting and normal proximal tubular PTH responsiveness even if they inherit the disease-associate allele.
###end p 52
###begin p 53
###xml 87 91 87 91 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GNAS</italic>
###xml 458 460 458 460 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R62">62</xref>
###xml 564 566 560 562 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R43">43</xref>
###xml 1256 1259 1240 1243 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R151">151</xref>
###xml 1353 1357 1337 1341 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GNAS</italic>
###xml 1378 1381 1362 1365 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R152">152</xref>
###xml 982 990 <span type="species:ncbi:9606">patients</span>
###xml 1142 1150 <span type="species:ncbi:9606">patients</span>
###xml 1316 1324 <span type="species:ncbi:9606">patients</span>
###xml 1498 1506 <span type="species:ncbi:9606">patients</span>
Sporadic PHP-Ib cases typically differ from familial PHP-Ib cases in the nature of the GNAS epigenetic defects they exhibit, yet evaluation of many cases with these PHP forms indicates that the divergence in the epigenetic features do not directly translate into differences in clinical presentation. The age of onset and the severity of hypocalcemia and hyperphosphatemia that result from PTH resistance appear to be similar in sporadic and familial cases [62]. As explained above, Gsalpha expression is also predominantly maternal in the pituitary somatotrophs [43]; however, growth hormone deficiency and short stature are not typical clinical features of PHP-Ib. It is possible that the epigenetic defects do not affect Gsalpha expression in this tissue, thereby allowing unimpaired GHRH signaling. This could suggest that the mechanisms underlying Gsalpha imprinting are different between the pituitary and the proximal tubule. Alternatively, GHRH resistance may be present in patients with PHP-Ib, but it may be too mild to become clinically manifest. This is similar to the TSH resistance in PHP-Ib, which can be absent in many PHP-Ib patients, is milder than in PHP-Ia, and can be accounted for by the partial imprinting of Gsalpha in the thyroid [151]. Mild short-stature has been recently reported in some patients who show PTH-resistance and GNAS imprinting defects [152], consistent with GHRH resistance and resultant growth hormone deficiency. Nevertheless, it remains unknown whether patients with PHP-Ib have reduced Gsalpha expression in the pituitary and whether they display GHRH resistance.
###end p 53
###begin p 54
###xml 60 64 60 64 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GNAS</italic>
###xml 354 357 354 357 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R166">166</xref>
###xml 435 441 435 441 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in cis</italic>
###xml 775 781 763 769 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in cis</italic>
###xml 846 848 834 836 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R81">81</xref>
###xml 849 852 837 840 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R88"> 88</xref>
###xml 960 964 948 952 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gnas</italic>
###xml 973 975 961 963 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R80">80</xref>
###xml 976 979 964 967 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R81"> 81</xref>
###xml 921 925 <span type="species:ncbi:10090">mice</span>
The common defect in nearly all PHP-Ib cases is the loss of GNAS exon A/B imprinting. In fact, this epigenetic defect is necessary for the development of PTH resistance, as documented in a PHP-Ib kindred in whom some individuals lacked both loss of A/B imprinting and PTH resistance despite maternally inheriting the disease-associated haplotype on 20q [166]. The loss of A/B imprinting on the maternal allele is predicted to silence, in cis, Gsalpha transcription in the proximal tubule. Therefore, methylation of exon A/B DMR and/or the repression of A/B transcription appear to be required for maternal Gsalpha expression in this and, probably, other tissues, such as the thyroid gland. Supporting this notion, ablation of the paternal exon A/B region derepresses Gsalpha in cis in tissues where this signaling protein is paternally silenced [81, 88] and, furthermore, rescues the PTH resistance phenotype observed in mice with a point mutation in maternal Gnas exon 6 [80, 81].
###end p 54
###begin title 55
###xml 21 25 21 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GNAS</italic>
ANIMAL MODELS OF THE GNAS-RELATED DISEASES
###end title 55
###begin title 56
PHP-Ia/PPHP
###end title 56
###begin p 57
###xml 43 47 43 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GNAS</italic>
###xml 176 178 172 174 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R40">40</xref>
###xml 556 560 552 556 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gnas</italic>
###xml 655 659 651 655 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gnas</italic>
###xml 663 665 659 661 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R67">67</xref>
###xml 887 891 879 883 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gnas</italic>
###xml 1341 1343 1329 1331 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R40">40</xref>
###xml 1857 1861 1841 1845 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GNAS</italic>
###xml 103 108 <span type="species:ncbi:10090">mouse</span>
###xml 523 527 <span type="species:ncbi:10090">mice</span>
###xml 622 626 <span type="species:ncbi:10090">mice</span>
###xml 718 726 <span type="species:ncbi:9606">patients</span>
###xml 798 806 <span type="species:ncbi:9606">patients</span>
###xml 908 912 <span type="species:ncbi:10090">mice</span>
###xml 997 1005 <span type="species:ncbi:9606">patients</span>
###xml 1049 1053 <span type="species:ncbi:10090">mice</span>
###xml 1408 1412 <span type="species:ncbi:10090">mice</span>
###xml 1549 1557 <span type="species:ncbi:9606">patients</span>
Before the evidence that several different GNAS transcripts, in addition to Gsalpha, utilize exon 2, a mouse model of PHP-Ia was generated by targeted disruption of this exon [40]. Homozygous disruption of exon 2 results in early embryonic lethality. Furthermore, paternal heterozygous disruption leads to lethality within the first 24 h after birth, and maternal heterozygous disruption results in death within the first three weeks. Surviving animals are fertile and appear to have normal life spans. As explained above, mice with paternal disruption of Gnas exon 2 have severe defects that are similar to those seen in mice with paternal disruption of Gnasxl [67], including reduced adiposity, which is not seen in patients with paternally inherited inactivating Gsalpha mutations (PPHP); these patients are typically overweight. On the other hand, both the maternal and the paternal Gnas exon 2 knockout mice appear smaller than their littermates, reminiscent of the short stature observed in patients with AHO. Furthermore, the exon 2 knockout mice prove to be a good model of PTH resistance. Reflecting the tissue-specific silencing of paternal Gsalpha in the proximal tubule, PTH-resistance, characterized by hypocalcemia, hyperphosphatemia, and elevated serum PTH, is present only after maternal inheritance of the disrupted allele [40]. In addition, PTH stimulation of proximal tubule extracts from mice with the maternal disruption, but not with the paternal disruption, fail to increase cAMP levels. Similar to the observations in PHP-Ia patients, the urine concentrating ability of the kidney in response to vasopressin is unimpaired in both the maternal and the paternal knockouts. Hence, although the findings resulted from the disruption of exon 2 are rather complicated due to the use of this exon by not only Gsalpha but also several other GNAS products (particularly XLalphas), this animal model is able to phenocopy PHP-Ia to a significant extent.
###end p 57
###begin p 58
###xml 5 12 5 12 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al. </italic>
###xml 13 15 13 15 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R82">82</xref>
###xml 33 40 33 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al. </italic>
###xml 41 43 41 43 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R41">41</xref>
###xml 129 133 129 133 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gnas</italic>
###xml 491 495 491 495 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gnas</italic>
###xml 641 643 641 643 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R41">41</xref>
###xml 904 907 900 903 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R144">144</xref>
###xml 974 978 970 974 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gnas</italic>
###xml 1041 1043 1037 1039 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R82">82</xref>
###xml 1215 1219 1211 1215 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gnas</italic>
###xml 1280 1282 1276 1278 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R41">41</xref>
###xml 1401 1405 1397 1401 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gnas</italic>
###xml 1539 1541 1523 1525 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R70">70</xref>
###xml 1542 1545 1526 1529 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R71"> 71</xref>
###xml 1546 1550 1530 1534 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R143"> 143</xref>
###xml 1692 1694 1668 1670 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R67">67</xref>
###xml 446 450 <span type="species:ncbi:10090">mice</span>
###xml 540 544 <span type="species:ncbi:10090">Mice</span>
###xml 649 655 <span type="species:ncbi:9606">humans</span>
###xml 827 835 <span type="species:ncbi:9606">patients</span>
###xml 884 892 <span type="species:ncbi:9606">patients</span>
###xml 951 955 <span type="species:ncbi:10090">mice</span>
###xml 1092 1097 <span type="species:ncbi:10090">mouse</span>
###xml 1196 1200 <span type="species:ncbi:10090">mice</span>
###xml 1317 1321 <span type="species:ncbi:10090">mice</span>
Chen et al. [82] and Germain-Lee et al. [41] have independently generated another model of PHP-Ia through targeted disruption of Gnas exon 1. In addition to early embryonic lethality observed upon homozygous inheritance of exon 1 disruption, even the heterozygous disruption is associated with some pre-weaning mortality regardless of the parental origin. While this finding is not observed in families with PHP-Ia/PPHP, the overall phenotype of mice heterozygous for maternal disruption of Gnas exon 1 resembles that of PHP-Ia remarkably. Mice with maternal disruption of exon 1 develop biochemical features consistent with PTH resistance [41]. In humans with inactivating Gsalpha mutations it is accepted that obesity develops regardless of the parent-of-origin of the introduced mutation, but recent evidence indicates that patients with PHP-Ia exhibit more prominent obesity than patients with PPHP [144]. Consistent with this recent observation, mice with the maternal Gnas exon 1 disruption is more obese than the paternal disruption [82]. In contrast to these similarities between the mouse models of exon 1 ablation and PHP-Ia/PPHP, the serum PTH level seems to be moderately elevated in mice with paternal Gnas exon 1 ablation, suggesting the presence of PTH-resistance [41]. This finding is not observed in mice with paternal ablation of exon 2 and may therefore reflect the preservation of Gnas transcripts that use exon 2, such as XLalphas. Although this conclusion is contrary to the evidence that XLalphas can mimic Gsalpha [70, 71, 143], it correlates well with the notion that Gsalpha and XLalphas, which are oppositely imprinted in certain tissues, mediate opposing actions [67].
###end p 58
###begin title 59
PHP-Ib
###end title 59
###begin p 60
###xml 48 53 48 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">STX16</italic>
###xml 193 197 193 197 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GNAS</italic>
###xml 325 330 325 330 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Stx16</italic>
###xml 342 345 342 345 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R167">167</xref>
###xml 680 684 680 684 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gnas</italic>
###xml 847 852 847 852 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Stx16</italic>
###xml 887 891 887 891 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gnas</italic>
###xml 959 964 959 964 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">STX16</italic>
###xml 1092 1097 1092 1097 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">STX16</italic>
###xml 1267 1271 1267 1271 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GNAS</italic>
###xml 1350 1355 1350 1355 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Stx16</italic>
###xml 219 223 <span type="species:ncbi:10090">mice</span>
###xml 228 234 <span type="species:ncbi:9606">humans</span>
###xml 270 275 <span type="species:ncbi:10090">mouse</span>
###xml 381 385 <span type="species:ncbi:10090">mice</span>
###xml 561 565 <span type="species:ncbi:10090">mice</span>
###xml 622 630 <span type="species:ncbi:9606">patients</span>
###xml 841 846 <span type="species:ncbi:10090">mouse</span>
###xml 1369 1373 <span type="species:ncbi:10090">mice</span>
Since a 3-kb deletion removing exons 4-6 of the STX16 locus has been identified in numerous familial PHP-Ib cases, and since this locus, with its exon-intron structure and its proximity to the GNAS locus, is similar in mice and humans, an attempt at generating a PHP-Ib mouse model has been made through targeted deletion of Stx16 exons 4-6 [167]. Both heterozygous and homozygous mice with this deletion lack gross abnormalities, are fertile, and appear to have a normal life span. More important, regardless of the parental origin of the deletion, the mutant mice fail to phenocopy the epigenetic abnormalities found in patients with familial PHP-Ib. In fact, neither any other Gnas methylation defects nor any biochemical features that would suggest PTH resistance could be observed in these animals. Thus, the nearly exact change in the mouse Stx16 gene is not sufficient to disrupt Gnas imprinting and to result in PTH resistance, ruling out a disrupted STX16 mRNA and/or protein as the molecular cause of familial PHP-Ib. This conclusion, which is consistent with the evidence that the STX16 locus is not imprinted, supports the hypothesis that the deletions in this gene disrupt a cis-acting long-range regulatory element required for the proper imprinting of GNAS exon A/B. It appears that this putative control element is not located within Stx16 exons 4-6 in mice.
###end p 60
###begin title 61
SUMMARY AND CONCLUSION 
###end title 61
###begin p 62
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GNAS</italic>
###xml 393 397 393 397 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GNAS</italic>
###xml 852 856 836 840 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GNAS</italic>
###xml 1131 1135 1111 1115 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GNAS</italic>
###xml 1446 1450 1418 1422 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GNAS</italic>
###xml 1650 1654 1622 1626 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GNAS</italic>
###xml 545 550 <span type="species:ncbi:9606">human</span>
GNAS is a complex locus located on the telomeric end of chromosome 20q. At least five distinct promoters reside in this locus, leading to biallelically, paternally, and/or maternally expressed transcripts from both the sense and antisense strands. Expression from this locus is tightly regulated by epigenetic mechanisms and cis-acting regulatory elements, including non-coding RNA molecules. GNAS encodes Gsalpha, one of the subunits of the heterotrimeric stimulatory G protein, which is essential for the actions of numerous agonists. Several human disorders are caused by heterozygous mutations that affect Gsalpha expression and/or activity, and consistent with the tissue-specific paternal silencing of Gsalpha expression, these disorders are inherited in a parent-of-origin specific manner. In contrast to Gsalpha, the roles of most of the other GNAS products remain unknown at the cellular and molecular level, even though the biological significance of these products are clear from gene knockout studies. Depending on their parental origin, mutations that affect the Gsalpha transcript also disrupt some of the additional GNAS transcripts, such as XLalphas. It is likely that the disruption of these additional gene products or alterations in the balance between the expression of Gsalpha and these proteins contributes to disease pathogenesis. It will therefore be important to investigate the factors regulating the expression of each GNAS product and to determine their cellular actions. Consequently, we will know more about the biological role of this gene locus and improve our understanding of the molecular mechanisms underlying the GNAS-related disorders. In addition, we will likely gain further insights into the functional significance of complex genes in the genome.
###end p 62
###begin title 63
REFERENCES
###end title 63
###begin article-title 64
###xml 39 44 <span type="species:ncbi:9606">human</span>
Initial sequencing and analysis of the human genome
###end article-title 64
###begin article-title 65
###xml 20 25 <span type="species:ncbi:9606">human</span>
The sequence of the human genome
###end article-title 65
###begin article-title 66
###xml 42 47 <span type="species:ncbi:9606">human</span>
Finishing the euchromatic sequence of the human genome
###end article-title 66
###begin article-title 67
###xml 26 31 <span type="species:ncbi:9606">human</span>
Quality assessment of the human genome sequence
###end article-title 67
###begin article-title 68
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human genome: end of the beginning
###end article-title 68
###begin article-title 69
###xml 13 18 <span type="species:ncbi:9606">human</span>
How to count human genes
###end article-title 69
###begin article-title 70
###xml 53 58 <span type="species:ncbi:9606">human</span>
Analysis of expressed sequence tags indicates 35,000 human genes
###end article-title 70
###begin article-title 71
###xml 27 32 <span type="species:ncbi:9606">human</span>
Gene index analysis of the human genome estimates approximately 120,000 genes
###end article-title 71
###begin article-title 72
###xml 12 17 <span type="species:ncbi:9606">human</span>
###xml 69 91 <span type="species:ncbi:99883">Tetraodon nigroviridis</span>
Estimate of human gene number provided by genome-wide analysis using Tetraodon nigroviridis DNA sequence
###end article-title 72
###begin article-title 73
Genetic mapping of the Gsalpha subunit gene (GNAS1) to the distal long arm of chromosome 20 using a polymorphism detected by denaturing gradient gel electrophoresis
###end article-title 73
###begin article-title 74
###xml 111 116 <span type="species:ncbi:9606">human</span>
G protein Gs alpha (GNAS 1), the probable candidate gene for Albright hereditary osteodystrophy is assigned to human chromosome 20q12-q13.2
###end article-title 74
###begin article-title 75
###xml 127 132 <span type="species:ncbi:9606">human</span>
Mapping of the gene encoding the alpha subunit of the stimulatory G protein of adenylyl cyclase (GNAS1) to 20q13.2----q13.3 in human by in situ hybridization
###end article-title 75
###begin article-title 76
###xml 90 95 <span type="species:ncbi:10090">mouse</span>
###xml 100 105 <span type="species:ncbi:9606">human</span>
Chromosomal localization of genes encoding guanine nucleotide-binding protein subunits in mouse and human
###end article-title 76
###begin article-title 77
###xml 51 56 <span type="species:ncbi:10090">mouse</span>
Mapping studies of the distal imprinting region of mouse chromosome 2
###end article-title 77
###begin article-title 78
Src tyrosine kinase is a novel direct effector of G proteins
###end article-title 78
###begin article-title 79
The stimulatory G protein of adenylyl cyclase, Gs, also stimulates dihydropyridine-sensitive Ca2+ channels. Evidence for direct regulation independent of phosphorylation by cAMP-dependent protein kinase or stimulation by a dihydropyridine agonist
###end article-title 79
###begin article-title 80
Splice variants of the alpha subunit of the G protein Gs activate both adenylyl cyclase and calcium channels
###end article-title 80
###begin article-title 81
GTPase mechanism of Gproteins from the 1.7-A crystal structure of transducin alpha-GDP-AIF-4
###end article-title 81
###begin article-title 82
Structures of active conformations of Gi alpha 1 and the mechanism of GTP hydrolysis
###end article-title 82
###begin article-title 83
###xml 93 98 <span type="species:ncbi:9606">human</span>
GTPase inhibiting mutations activate the alpha chain of Gs and stimulate adenylyl cyclase in human pituitary tumours
###end article-title 83
###begin article-title 84
###xml 13 29 <span type="species:ncbi:562">Escherichia coli</span>
Synthesis in Escherichia coli of GTPase-deficient mutants of Gs alpha
###end article-title 84
###begin article-title 85
Insights into G protein structure, function, and regulation
###end article-title 85
###begin article-title 86
###xml 58 63 <span type="species:ncbi:9606">human</span>
Introduction to G-protein-coupled signal transduction and human disease
###end article-title 86
###begin article-title 87
###xml 38 43 <span type="species:ncbi:9606">human</span>
Isolation and characterization of the human Gsalpha gene
###end article-title 87
###begin article-title 88
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human cDNA clones for four species of G alpha s signal transduction protein
###end article-title 88
###begin article-title 89
Molecular basis for two forms of the G protein that stimulates adenylate cyclase
###end article-title 89
###begin article-title 90
The regulatory component of adenylate cyclase. Purification and properties
###end article-title 90
###begin article-title 91
Increase in Gs and cyclic AMP generation in HIT cells. Evidence that the 45-kDa alpha-subunit of Gs has greater functional activity than the 52-kDa alpha-subunit
###end article-title 91
###begin article-title 92
###xml 26 42 <span type="species:ncbi:562">Escherichia coli</span>
Expression of Gs alpha in Escherichia coli. Purification and properties of two forms of the protein
###end article-title 92
###begin article-title 93
Different effects of Gsalpha splice variants on beta2-adrenoreceptor-mediated signaling. The beta2-adreno-receptor coupled to the long splice variant of Gsalpha has properties of a constitutively active receptor
###end article-title 93
###begin article-title 94
The short and long forms of the alpha subunit of the stimulatory guanine-nucleotide-binding protein are unequally redistributed during (-)-isoproterenol-mediated desensitization of intact S49 lymphoma cells
###end article-title 94
###begin article-title 95
Long-term effect of forskolin on the activation of adenylyl cyclase in astrocytes
###end article-title 95
###begin article-title 96
###xml 24 29 <span type="species:ncbi:9606">human</span>
G protein expression in human fetoplacental vascularization. Functional evidence for Gs alpha and Gi alpha subunits
###end article-title 96
###begin article-title 97
A disruptive mutation in exon 3 of the GNAS gene with albright hereditary osteodystrophy, normocalcemic pseudohypoparathyroidism, and selective long transcript variant Gsalpha-L deficiency
###end article-title 97
###begin article-title 98
Neural expression of a novel alternatively spliced and polyadenylated Gs alpha transcript
###end article-title 98
###begin article-title 99
###xml 4 9 <span type="species:ncbi:9606">human</span>
The human GNAS1 gene is imprinted and encodes distinct paternally and biallelically expressed G proteins
###end article-title 99
###begin article-title 100
Bidirectional imprinting of a single gene: GNAS1 encodes maternally, paternally, and biallelically derived proteins
###end article-title 100
###begin article-title 101
###xml 55 60 <span type="species:ncbi:9606">human</span>
Galphas transcripts are biallelically expressed in the human kidney cortex: implications for pseudohypoparathyroidism type Ib
###end article-title 101
###begin article-title 102
###xml 42 47 <span type="species:ncbi:9606">human</span>
Parental origin of transcription from the human GNAS1 gene
###end article-title 102
###begin article-title 103
###xml 67 68 67 68 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">s</sub>
###xml 93 94 89 90 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">s</sub>
###xml 110 114 <span type="species:ncbi:10090">mice</span>
Variable and tissue-specific hormone resistance in heterotrimeric Gs protein alpha-subunit (Gsalpha) knockout mice is due to tissue-specific imprinting of the Gsalpha gene
###end article-title 103
###begin article-title 104
###xml 2 7 <span type="species:ncbi:10090">Mouse</span>
A Mouse Model of Albright Hereditary Osteodystrophy Generated by Targeted Disruption of Exon 1 of the Gnas Gene
###end article-title 104
###begin article-title 105
Tissue-specific imprinting of the G protein Gsalpha is associated with tissue-specific differences in histone methylation
###end article-title 105
###begin article-title 106
Imprinting of the G(s)alpha gene GNAS1 in the pathogenesis of acromegaly
###end article-title 106
###begin article-title 107
###xml 66 71 <span type="species:ncbi:9606">Human</span>
The Gsalpha Gene: Predominant Maternal Origin of Transcription in Human Thyroid Gland and Gonads
###end article-title 107
###begin article-title 108
###xml 40 45 <span type="species:ncbi:9606">human</span>
Paternal imprinting of Galpha(s) in the human thyroid as the basis of TSH resistance in pseudohypoparathyroidism type 1a
###end article-title 108
###begin article-title 109
###xml 44 49 <span type="species:ncbi:9606">human</span>
Biallelic expression of the Gsalpha gene in human bone and adipose tissue
###end article-title 109
###begin article-title 110
GNAS transcripts in skeletal progenitors: evidence for random asymmetric allelic expression of Gs{alpha}
###end article-title 110
###begin article-title 111
###xml 23 27 <span type="species:ncbi:10090">mice</span>
Regulation of renin in mice with cre recombinase-mediated deletion of G protein Gs{alpha} in juxtaglomerular cells
###end article-title 111
###begin article-title 112
###xml 92 96 <span type="species:ncbi:10090">mice</span>
Increased glucose tolerance and reduced adiposity in the absence of fasting hypoglycemia in mice with liver-specific Gs alpha deficiency
###end article-title 112
###begin article-title 113
Chondrocyte-specific knockout of the G protein G(s)alpha leads to epiphyseal and growth plate abnormalities and ectopic chondrocyte formation
###end article-title 113
###begin article-title 114
Deficiency of the G protein alpha -subunit Gsalpha in osteoblasts leads to differential effects on trabecular and cortical bone
###end article-title 114
###begin article-title 115
###xml 99 104 <span type="species:ncbi:10090">mouse</span>
A cluster of oppositely imprinted transcripts at the Gnas locus in the distal imprinting region of mouse chromosome 2
###end article-title 115
###begin article-title 116
Molecular cloning and characterization of NESP55, a novel chromogranin-like precursor of a peptide with 5-HT1B receptor antagonist activity
###end article-title 116
###begin article-title 117
###xml 58 64 <span type="species:ncbi:9913">bovine</span>
Relative amounts and molecular forms of NESP55 in various bovine tissues
###end article-title 117
###begin article-title 118
Neuroendocrine secretory protein 55 (NESP55): alternative splicing onto transcripts of the GNAS gene and posttranslational processing of a maternally expressed protein
###end article-title 118
###begin article-title 119
###xml 109 115 <span type="species:ncbi:9913">bovine</span>
###xml 120 123 <span type="species:ncbi:10116">rat</span>
The new chromogranin-like protein NESP55 is preferentially localized in adrenaline-synthesizing cells of the bovine and rat adrenal medulla
###end article-title 119
###begin article-title 120
Neuroendocrine secretory protein 55: a novel marker for the constitutive secretory pathway
###end article-title 120
###begin article-title 121
###xml 104 107 <span type="species:ncbi:10116">rat</span>
Distribution and intraneuronal trafficking of a novel member of the chromogranin family, NESP55, in the rat peripheral nervous system
###end article-title 121
###begin article-title 122
Secretion and molecular forms of NESP55, a novel genomically imprinted neuroendocrine-specific protein from AtT-20 cells
###end article-title 122
###begin article-title 123
Imprinted Nesp55 influences behavioral reactivity to novel environments
###end article-title 123
###begin article-title 124
###xml 73 76 <span type="species:ncbi:10116">rat</span>
Localization of neuroendocrine secretory protein 55 messenger RNA in the rat brain
###end article-title 124
###begin article-title 125
###xml 44 52 <span type="species:ncbi:9606">patients</span>
Similar clinical and laboratory findings in patients with symptomatic autosomal dominant and sporadic pseudohypoparathyroidism type Ib despite different epigenetic changes at the GNAS locus
###end article-title 125
###begin article-title 126
A GNAS1 imprinting defect in pseudohypoparathyroidism type IB
###end article-title 126
###begin article-title 127
XLalphas is a new type of G protein (Erratum in Nature 1995 375:253)
###end article-title 127
###begin article-title 128
Tissue-specific expression of antisense and sense transcripts at the imprinted Gnas locus
###end article-title 128
###begin article-title 129
Characterization of the extra-large G protein alpha-subunit XLalphas.I. Tissue distribution and subcellular localization
###end article-title 129
###begin article-title 130
The imprinted signaling protein XLalphas is required for postnatal adaptation to feeding
###end article-title 130
###begin article-title 131
###xml 132 135 <span type="species:ncbi:10116">rat</span>
Expression of the extra-large G protein alpha-subunit XLalphas in neuroepithelial cells and young neurons during development of the rat nervous system
###end article-title 131
###begin article-title 132
Characterization of the extra-large G protein alpha-subunit XLalphas. II. Signal transduction properties
###end article-title 132
###begin article-title 133
###xml 59 67 59 67 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 162 167 <span type="species:ncbi:9606">human</span>
Coding GNAS mutations leading to hormone resistance impair in vitro agonist- and cholera toxin-induced adenosine cyclic 3',5'-monophosphate formation mediated by human XLalphas
###end article-title 133
###begin article-title 134
Receptor-Mediated Adenylyl Cyclase Activation Through XLalphas, the Extra-Large Variant of the Stimulatory G Protein alpha-Subunit
###end article-title 134
###begin article-title 135
XLalphas, the extra-long form of the alpha-subunit of the Gs G protein, is significantly longer than suspected, and so is its companion Alex
###end article-title 135
###begin article-title 136
Two overlapping reading frames in a single exon encode interacting proteins--a novel way of gene usage
###end article-title 136
###begin article-title 137
Functional polymorphisms in the paternally expressed XLalphas and its cofactor ALEX decrease their mutual interaction and enhance receptor-mediated cAMP formation
###end article-title 137
###begin article-title 138
Genetic variation of the extra-large stimulatory G protein alpha-subunit leads to Gs hyperfunction in platelets and is a risk factor for bleeding
###end article-title 138
###begin article-title 139
###xml 158 162 <span type="species:ncbi:10090">mice</span>
The alternative stimulatory G protein alpha-subunit XLalphas is a critical regulator of energy and glucose metabolism and sympathetic nerve activity in adult mice
###end article-title 139
###begin article-title 140
###xml 50 54 <span type="species:ncbi:10090">mice</span>
Increased insulin sensitivity in Gsalpha knockout mice
###end article-title 140
###begin article-title 141
Paternal versus maternal transmission of a stimulatory G-protein alpha subunit knockout produces opposite effects on energy metabolism
###end article-title 141
###begin article-title 142
###xml 56 60 <span type="species:ncbi:10090">mice</span>
Increased insulin sensitivity in paternal Gnas knockout mice is associated with increased lipid clearance
###end article-title 142
###begin article-title 143
###xml 43 48 <span type="species:ncbi:10090">mouse</span>
The imprinted oedematous-small mutation on mouse chromosome 2 identifies new roles for gnas and gnasxl in development
###end article-title 143
###begin article-title 144
A cis-acting control region is required exclusively for the tissue-specific imprinting of Gnas
###end article-title 144
###begin article-title 145
Alternative Gnas gene products have opposite effects on glucose and lipid metabolism
###end article-title 145
###begin article-title 146
###xml 72 77 <span type="species:ncbi:9606">girls</span>
Paternal deletion of the GNAS imprinted locus (including Gnasxl) in two girls presenting with severe pre- and postnatal growth retardation and intractable feeding difficulties
###end article-title 146
###begin article-title 147
Differential expression of novel Gs alpha signal transduction protein cDNA species
###end article-title 147
###begin article-title 148
###xml 56 61 <span type="species:ncbi:10090">mouse</span>
Identification of a methylation imprint mark within the mouse gnas locus
###end article-title 148
###begin article-title 149
###xml 51 52 51 52 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">s</sub>
Alternative promoter and 5' exon generate a novel Gsalpha mRNA
###end article-title 149
###begin article-title 150
Activating and silencing histone modifications form independent allelic switch regions in the imprinted Gnas gene
###end article-title 150
###begin article-title 151
Identification of the control region for tissue-specific imprinting of the stimulatory G protein alpha-subunit
###end article-title 151
###begin article-title 152
###xml 219 224 219 224 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GNAS1</italic>
Positional dissociation between the genetic mutation responsible for pseudohypoparathyroidism type Ib and the associated methylation defect at exon A/B: evidence for a long-range regulatory element within the imprinted GNAS1 locus
###end article-title 152
###begin article-title 153
###xml 92 97 92 97 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GNAS1</italic>
Paternal uniparental isodisomy of chromosome 20q (patUPD20q) - and the resulting changes in GNAS1 methylation - as a plausible cause of pseudohypoparathyroidism
###end article-title 153
###begin article-title 154
Methylation of a CTCF-dependent boundary controls imprinted expression of the Igf2 gene
###end article-title 154
###begin article-title 155
CTCF mediates methylation-sensitive enhancer-blocking activity at the H19/Igf2 locus
###end article-title 155
###begin article-title 156
###xml 41 46 <span type="species:ncbi:9606">human</span>
An imprinted antisense transcript at the human GNAS1 locus
###end article-title 156
###begin article-title 157
###xml 101 106 <span type="species:ncbi:10090">mouse</span>
An imprinted transcript, antisense to Nesp, adds complexity to the cluster of imprinted genes at the mouse Gnas locus
###end article-title 157
###begin article-title 158
###xml 93 98 <span type="species:ncbi:10090">mouse</span>
Epigenetic properties and identification of an imprint mark in the Nesp-Gnasxl domain of the mouse Gnas imprinted locus
###end article-title 158
###begin article-title 159
Identification of an imprinting control region affecting the expression of all transcripts in the Gnas cluster
###end article-title 159
###begin article-title 160
###xml 27 32 <span type="species:ncbi:9606">human</span>
Two G protein oncogenes in human endocrine tumors
###end article-title 160
###begin article-title 161
Endocrine Manifestations of Stimulatory G Protein alpha-Subunit Mutations and the Role of Genomic Imprinting
###end article-title 161
###begin article-title 162
###xml 101 106 <span type="species:ncbi:9606">human</span>
Activating mutation of the stimulatory G protein (gsp) as a putative cause of ovarian and testicular human stromal Leydig cell tumors
###end article-title 162
###begin article-title 163
Activating mutations of the stimulatory g protein in juvenile ovarian granulosa cell tumors: a new prognostic factor?
###end article-title 163
###begin article-title 164
Activating mutations of Gsalpha in kidney cancer
###end article-title 164
###begin article-title 165
###xml 106 121 <span type="species:ncbi:10090">transgenic mice</span>
Thyroid-specific expression of cholera toxin A1 subunit causes thyroid hyperplasia and hyperthyroidism in transgenic mice
###end article-title 165
###begin article-title 166
Expression of mutationally activated G alpha s stimulates growth and differentiation of thyroid FRTL5 cells
###end article-title 166
###begin article-title 167
Conditional overexpression of the wild-type Gs alpha as the gsp oncogene initiates chronic extracellularly regulated kinase 1/2 activation and hormone hypersecretion in pituitary cell lines
###end article-title 167
###begin article-title 168
###xml 54 58 <span type="species:ncbi:9606">girl</span>
Osteitis fibrosa cystica; the case of a nine-year old girl who also exhibits precocious puberty, multiple pigmentation of the skin and hyperthyroidism
###end article-title 168
###begin article-title 169
Syndrome characterized by osteitis fibrosa disseminata, areas of pigmentation and endocrine dysfunction, with precocious puberty in females
###end article-title 169
###begin article-title 170
Activating mutations of the stimulatory G protein in the McCune-Albright syndrome
###end article-title 170
###begin article-title 171
Identification of a mutation in the gene encoding the alpha subunit of the stimulatory G protein of adenylyl cyclase in McCune-Albright syndrome
###end article-title 171
###begin article-title 172
The McCune-Albright syndrome: a lethal gene surviving by mosaicism
###end article-title 172
###begin article-title 173
Mutations of the GNAS1 gene, stromal cell dysfunction, and osteomalacic changes in non-McCune-Albright fibrous dysplasia of bone
###end article-title 173
###begin article-title 174
An activating Gs alpha mutation is present in fibrous dysplasia of bone in the McCune-Albright syndrome
###end article-title 174
###begin article-title 175
A sensitive mutation-specific screening technique for GNAS1 mutations in cases of fibrous dysplasia: the first report of a codon 227 mutation in bone
###end article-title 175
###begin article-title 176
The McCune-Albright syndrome
###end article-title 176
###begin article-title 177
The McCune-Albright syndrome
###end article-title 177
###begin article-title 178
###xml 84 91 <span type="species:ncbi:9606">patient</span>
Mammosomatotroph hyperplasia associated with acromegaly and hyperprolactinemia in a patient with the McCune-Albright syndrome. A histologic, immunocytologic and ultrastructural study of the surgically-removed adenohypophysis
###end article-title 178
###begin article-title 179
###xml 112 120 <span type="species:ncbi:9606">patients</span>
The role of fibroblast growth factor 23 for hypophosphatemia and abnormal regulation of vitamin D metabolism in patients with McCune-Albright syndrome
###end article-title 179
###begin article-title 180
Expression of FGF23 is correlated with serum phosphate level in isolated fibrous dysplasia
###end article-title 180
###begin article-title 181
FGF-23 in fibrous dysplasia of bone and its relationship to renal phosphate wasting
###end article-title 181
###begin article-title 182
###xml 52 58 <span type="species:ncbi:9031">Bantam</span>
Pseudohypoparathyroidism - an example of "Seabright-Bantam syndrome"
###end article-title 182
###begin article-title 183
AG protein-linked receptor for parathyroid hormone and parathyroid hormone-related peptide
###end article-title 183
###begin article-title 184
###xml 109 112 <span type="species:ncbi:10116">rat</span>
Expression cloning of a common receptor for parathyroid hormone and parathyroid hormone-related peptide from rat osteoblast-like cells: a single receptor stimulates intracellular accumulation of both cAMP and inositol triphosphates and increases intracellular free calcium
###end article-title 184
###begin article-title 185
Parathyroid hormone: past and present
###end article-title 185
###begin article-title 186
Parathyroid hormone and parathyroid hormone-related peptide, and their receptors
###end article-title 186
###begin article-title 187
###xml 82 87 <span type="species:ncbi:9606">human</span>
Studies on the physiology of the parathyroid glands. VII.Some responses of normal human kidneys and blood to intravenous parathyroid extract
###end article-title 187
###begin article-title 188
Pseudohypoparathyroidism: defective excretion of 3',5'-AMP in response to parathyroid hormone
###end article-title 188
###begin article-title 189
Genetic deficiency of the alpha subunit of the guanine nucleotide-binding protein Gs as the molecular basis for Albright hereditary osteodystrophy
###end article-title 189
###begin article-title 190
###xml 97 105 <span type="species:ncbi:9606">patients</span>
Immunochemical analysis of the alpha-subunit of the stimulatory G-protein of adenylyl cyclase in patients with Albright's hereditary osteodystrophy
###end article-title 190
###begin article-title 191
Reduced expression of multiple forms of the alphasubunit of the stimulatory GTP-binding protein in pseudohypoparathyroidism type Ia
###end article-title 191
###begin article-title 192
Mutations of the Gs alpha-subunit gene in Albright hereditary osteodystrophy detected by denaturing gradient gel electrophoresis
###end article-title 192
###begin article-title 193
Mutation in the gene encoding the stimulatory G protein of adenylate cyclase in Albright's hereditary osteodystrophy
###end article-title 193
###begin article-title 194
###xml 35 43 <span type="species:ncbi:9606">patients</span>
Resistance to multiple hormones in patients with pseudohypoparathyroidism. Association with deficient activity of guanine nucleotide regulatory protein
###end article-title 194
###begin article-title 195
###xml 89 96 <span type="species:ncbi:9606">patient</span>
Coupling defect of thyrotropin receptor and adenylate cyclase in a pseudohypoparathyroid patient
###end article-title 195
###begin article-title 196
Partial gonadotrophin-resistance in pseudohypoparathyroidism
###end article-title 196
###begin article-title 197
Growth hormone-releasing hormone resistance in pseudohypoparathyroidism type ia: new evidence for imprinting of the Gs alpha gene
###end article-title 197
###begin article-title 198
Growth hormone deficiency in pseudohypoparathyroidism type 1a: another manifestation of multihormone resistance
###end article-title 198
###begin article-title 199
Pseudohypoparathyroidism: its phenotypic variability and associated disorders in a large family
###end article-title 199
###begin article-title 200
###xml 95 103 <span type="species:ncbi:9606">patients</span>
Evidence for normal antidiuretic responses to endogenous and exogenous arginine vasopressin in patients with guanine nucleotide-binding stimulatory protein-deficient pseudohypoparathyroidism
###end article-title 200
###begin article-title 201
Deficient erythrocyte membrane Gs alpha activity and resistance to trophic hormones of multiple endocrine organs in two cases of pseudohypoparathyroidism
###end article-title 201
###begin article-title 202
Pseudo-pseudohypo-parathyroidism
###end article-title 202
###begin article-title 203
###xml 95 103 <span type="species:ncbi:9606">patients</span>
Activity of the stimulatory guanine nucleotide-binding protein is reduced in erythrocytes from patients with pseudohypoparathyroidism and pseudohypoparathyroidism: Biochemical, endocrine, and genetic analysis of Albright's hereditary osteodystrophy in six kindreds
###end article-title 203
###begin article-title 204
Imprinting in Albright's hereditary osteodystrophy
###end article-title 204
###begin article-title 205
Parental origin of Gsalpha gene mutations in Albright's hereditary osteodystrophy
###end article-title 205
###begin article-title 206
###xml 96 103 96 103 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
Stimulatory G protein directly regulates hypertrophic differentiation of growth plate cartilage in vivo
###end article-title 206
###begin article-title 207
###xml 171 176 <span type="species:ncbi:9606">human</span>
Body mass index differences in pseudohypoparathyroidism type 1a versus pseudopseudohypoparathyroidism may implicate paternal imprinting of Galpha(s) in the development of human obesity
###end article-title 207
###begin article-title 208
Progressive osseous heteroplasia
###end article-title 208
###begin article-title 209
Deficiency of the alpha-subunit of the stimulatory G protein and severe extraskeletal ossification
###end article-title 209
###begin article-title 210
Paternally inherited inactivating mutations of the GNAS1 gene in progressive osseous heteroplasia
###end article-title 210
###begin article-title 211
GNAS1 mutations and progressive osseous heteroplasia
###end article-title 211
###begin article-title 212
###xml 50 55 <span type="species:ncbi:9606">child</span>
Progressive osseous heteroplasia in the face of a child
###end article-title 212
###begin article-title 213
Progressive osseous heteroplasia resulting from a new mutation in the GNAS1 gene
###end article-title 213
###begin article-title 214
###xml 64 69 <span type="species:ncbi:9606">human</span>
The stimulatory G protein alpha-subunit Gsalpha is imprinted in human thyroid glands: implications for thyroid function in pseudohypoparathyroidism types 1A and 1B
###end article-title 214
###begin article-title 215
###xml 30 38 <span type="species:ncbi:9606">patients</span>
Epigenetic defects of GNAS in patients with pseudohypoparathyroidism and mild features of Albright's hereditary osteodystrophy
###end article-title 215
###begin article-title 216
###xml 78 86 <span type="species:ncbi:9606">patients</span>
Selective resistance to parathyroid hormone in cultured skin fibroblasts from patients with pseudohypoparathyroidism type Ib
###end article-title 216
###begin article-title 217
Selective resistance to parathyroid hormone caused by a novel uncoupling mutation in the carboxyl terminus of Galphas: A cause of pseudohypoparathyroidism type Ib
###end article-title 217
###begin article-title 218
###xml 87 92 <span type="species:ncbi:9606">human</span>
Pseudohypoparathyroidism type Ib is not caused by mutations in the coding exons of the human parathyroid hormone (PTH)/PTH-related peptide receptor gene
###end article-title 218
###begin article-title 219
###xml 118 126 <span type="species:ncbi:9606">patients</span>
Absence of mutations in parathyroid hormone (PTH)/PTH-related protein receptor complementary deoxyribonucleic acid in patients with pseudohypoparathyroidism type Ib
###end article-title 219
###begin article-title 220
Pseudohypoparathyroidism 1b: exclusion of parathyroid hormone and its receptors as candidate disease genes
###end article-title 220
###begin article-title 221
The gene responsible for pseudohypoparathyroidism type Ib is paternally imprinted and maps in four unrelated kindreds to chromosome 20q13.3
###end article-title 221
###begin article-title 222
The pseudohypoparathyroidism type lb locus is linked to a region including GNAS1 at 20q13.3
###end article-title 222
###begin article-title 223
Autosomal dominant pseudohypoparathyroidism type Ib is associated with a heterozygous microdeletion that likely disrupts a putative imprinting control element of GNAS
###end article-title 223
###begin article-title 224
Molecular diagnosis of pseudohypoparathyroidism type Ib in a family with presumed paroxysmal dyskinesia
###end article-title 224
###begin article-title 225
Distinct patterns of abnormal GNAS imprinting in familial and sporadic pseudohypoparathyroidism type IB
###end article-title 225
###begin article-title 226
Phenotypic and molecular genetic aspects of pseudohypoparathyroidism type ib in a Greek kindred: evidence for enhanced uric acid excretion due to parathyroid hormone resistance
###end article-title 226
###begin article-title 227
A Novel STX16 Deletion in Autosomal Dominant Pseudohypoparathyroidism Type Ib Redefines the Boundaries of a cis-Acting Imprinting Control Element of GNAS
###end article-title 227
###begin article-title 228
Deletion of the NESP55 differentially methylated region causes loss of maternal GNAS imprints and pseudohypoparathyroidism type-Ib
###end article-title 228
###begin article-title 229
Discordance between genetic and epigenetic defects in pseudohypoparathyroidism type 1b revealed by inconsistent loss of maternal imprinting at GNAS1
###end article-title 229
###begin article-title 230
###xml 72 76 <span type="species:ncbi:10090">mice</span>
Lack of Gnas epigenetic changes and pseudohypoparathyroidism type Ib in mice with targeted disruption of syntaxin-16
###end article-title 230
###begin p 231
###xml 68 72 68 72 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GNAS</italic>
###xml 543 547 531 535 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GNAS</italic>
###xml 933 937 921 925 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GNAS</italic>
###xml 1331 1335 1319 1323 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GNAS</italic>
Multiple imprinted sense and antisense transcripts from the complex GNAS locus. Exons 1-13 encode Gsalpha , which is biallelic in most tissues; however, paternal Gsalpha allele is silenced in a small number of tissues, including the renal proximal tubule, thyroid, and pituitary. From differentially methylated promoters arise several other transcripts, including the maternally expressed NESP55 and the paternally expressed XLalphas. Both of these transcripts use individual first exons that splice onto exons 2-13. In addition, the paternal GNAS allele gives rise to a transcript termed A/B (also referred to as 1A or 1'), which also shares exons 2-13 and is presumed to be non-coding. Note that the A/B transcript contains an ORF (colored grey) that could lead to a translational product, but the existence of endogenous A/B protein is not supported experimentally. Another non-coding transcript is also derived from the paternal GNAS allele, but this transcript is made from the antisense strand (AS transcript). Boxes and connecting lines depict exons and introns, respectively. Open rectangles and rectangles filled with CH3 show non-methylated and methylated DMRs, respectively. The distance between AS exon 5 and exon NESP55 is ~19 kb and the distance between exon A/B and exon XL ~35 kb. Maternal (mat) and paternal (pat) GNAS products are illustrated above and below the gene structure, respectively, with splicing patterns indicated by broken lines. Filled boxes indicate untranslated sequences.
###end p 231
###begin p 232
Splice variants of Gsalpha. Alternative splicing of exon 3 leads to Gsalpha-L and Gsalpha-S, each of which has subvariants due to alternative splicing of a serine codon at the start of exon 4. Gsalpha-N1 is formed through the use of an exon that comprises an in-frame termination codon and is located between exons 3 and 4. Boxes and connecting lines depict exons and introns, respectively. The alternatively spliced serine codon is depicted as a circle. Splicing patterns are indicated by broken lines. Filled boxes indicate 5' and 3' untranslated regions.
###end p 232
###begin p 233
XLalphas and its multiple variants. XLalphas is derived from a promoter upstream of that which drives the expression of Gsalpha . Panel A. Alternative splicing leads to different XLalphas variants that are analogues to Gsalpha variants. In addition, an N-terminally extended XLalphas variant, termed XXLalphas, is made, representing the 5' extension of the ORF. For simplicity, GNAS exons located upstream of exon XL are not shown. Panel B. XLalphas and XXLalphas mRNA include two ORFs each. The second ORF leads to ALEX or ALEXX, respectively.
###end p 233
###begin p 234
###xml 39 43 39 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GNAS</italic>
###xml 64 68 64 68 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GNAS</italic>
###xml 486 490 482 486 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GNAS</italic>
###xml 577 582 573 578 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">STX16</italic>
###xml 749 753 745 749 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GNAS</italic>
###xml 1058 1062 1054 1058 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GNAS</italic>
###xml 1168 1173 <span type="species:ncbi:10090">mouse</span>
Regulation of gene expression from the GNAS locus. The maternal GNAS allele comprises two germ-line imprint marks, one at the AS promoter and the other at exon A/B. Ablation of the non-methylated, paternal AS promoter causes derepression of NESP55, and ablation of the non-methylated, paternal exon A/B leads to derepression of Gsalpha; the latter occurs in tissues where the latter is normally silenced from the paternal allele (*). Most familial PHP-Ib cases exhibit isolated loss of GNAS exon A/B imprinting. Deletions identified in those cases point to a region within the STX16 locus, probably around exon 4, as comprising a cis-acting long-range regulatory element that is necessary for the establishment of the maternal exon A/B imprint. All GNAS maternal imprints are lost in most sporadic and some familial PHP-Ib cases. Deletions identified in the latter suggest that the NESP55 DMR, which contains not only exon NESP55 but also exons 3 and 4 of the AS transcript, comprises a cis-acting element that controls the imprinting of the entire maternal GNAS allele. Arrows indicate the regulatory effects revealed by mutations in PHP-Ib and the study of knockout mouse models. mat, maternal; pat, paternal.
###end p 234

